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Abstract
Modeling interstitial fluid flow involves processes such as fluid diffusion, convective
transport in the extracellular matrix, and extravasation from blood vessels. In all of
these processes, computational fluid dynamics can play a crucial role in elucidating the
mechanisms of fluid flow in solid tumors and surrounding tissues. To date, microvasculature
flow modeling has been most extensively studied with simple tumor shapes and their
capillaries at different levels and scales. With our proposed numerical model, however,
more complex and realistic tumor shapes and capillary networks can be studied.
First, a mathematical model of interstitial fluid flow is developed, based on the appli-
cation of the governing equations for fluid flow, i.e., the conservation laws for mass and
momentum, to physiological systems containing solid tumors. Simulations of interstitial
fluid transport in a homogeneous solid tumor demonstrate that, in a uniformly perfused
tumor, i.e., one with no necrotic region, the interstitial pressure distribution results in
a non-uniform distribution of drug particles. Pressure distribution for different values of
necrotic radii is examined, and two new parameters, the critical tumor radius and critical
necrotic radius, are defined. In specific ranges of these critical dimensions the interstitial
fluid pressure is relatively lower, which in turn leads to a diminished opposing force against
drug movement and a subsequently higher drug concentration and potentially enhanced
therapeutic effects.
In this work, the numerical model of fluid flow in solid tumors is further developed to
incorporate and investigate non-spherical tumor shapes such as prolate and oblate ones.
Using this enhanced model, tumor shape and size effects on drug delivery to solid tumors
are then studied. Based on the assumption that drug particles flow with the interstitial
fluid, the pressure and velocity maps of the latter are used to illustrate the drug delivery
pattern in a solid tumor. Additionally, the effects of the surface area per unit volume
of the tissue, as well as vascular and interstitial hydraulic conductivity on drug delivery
efficiency, are investigated.
Using a tumor-induced microvasculature architecture instead of a uniform distribution
of vessels provides a more realistic model of solid tumors. To this end, continuous and
discrete mathematical models of angiogenesis were utilized to observe the effect of matrix
density and matrix degrading enzymes on capillary network formation in solid tumors.
Additionally, the interactions between matrix-degrading enzymes, the extracellular matrix
and endothelial cells are mathematically modeled. Existing continuous and discrete models
of angiogenesis were modified to impose the effect of matrix density on the solution. The
imposition has been performed by a specific function in movement potential. Implement-
ing realistic boundary and initial conditions showed that, unlike in previous models, the
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endothelial cells accelerate as they migrate toward the tumor. Now, the tumor-induced
microvasculature network can be applied to the model developed in Chapters 2 and 3.
Once the capillary network was set up, fluid flow in normal and cancerous tissues
was numerically simulated under three conditions: constant and uniform distribution of
intravascular pressure in the whole domain, a rigid vascular network, and an adaptable
vascular network. First, governing equations of sprouting angiogenesis were implemented
to specify the different domains for the network and interstitium. Governing equations
for flow modeling were introduced for different domains. The conservation laws for mass
and momentum, Darcys equation for tissue, and a simplified Navier Stokes equation for
blood flow through capillaries were then used for simulating interstitial and intravascular
flows. Finally, Starlings law was used to close this system of equations and to couple
the intravascular and extravascular flows. The non-continuous behavior of blood and the
adaptability of capillary diameter to hemodynamics and metabolic stimuli were considered
in blood flow simulations through a capillary network. This approach provided a more
realistic capillary distribution network, very similar to that of the human body.
This work describes the first study of flow modeling in solid tumors to realistically
couple intravascular and extravascular flow through a network generated by sprouting
angiogenesis, consisting of one parent vessel connected to the network. Other key factors
incorporated in the model for the first time include capillary adaptation, non-continuous
viscosity blood, and phase separation of blood flow in capillary bifurcation. Contrary to
earlier studies which arbitrarily assumed veins and arteries to operate on opposite sides of a
tumor network, the present approach requires the same vessel to run and from the network.
Expanding the earlier models by introducing the outlined components was performed in
order to achieve a more-realistic picture of blood flow through solid tumors. Results predict
an almost doubled interstitial pressure and are in better agreement with human biology
compared to the more simplified models generally in use today.
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Although heart and blood vessel diseases were the main causes of death for many years,
more than 12 million new cancer diagnoses were reported in 2011, making it the new lead-
ing cause of death. At least 30% of people develop cancer, and 25% of men’s and 20% of
women’s deaths are due to it. More than 85% of cancers involve solid tumors [43]. Since
cancer arises from disturbances in cell proliferation, differentiation, and development, un-
derstanding each of these mechanisms that may lead to tumor formation is very important
in finding more effective therapies. Because of its complexity in formation, development,
and cure, cancer is known as one of the main medical challenges worldwide. This challenge
is more highlighted in mathematical modeling of tumor development and related blood
flow and transport.
Modeling interstitial fluid flow involves processes such as fluid diffusion, convective
transport in extracellular matrices, and extravasation from blood vessels. In all of these
processes, computational fluid dynamics (CFD) can play a crucial role in elucidating the
mechanisms of fluid flow in solid tumors and surrounding tissues. The research conducted
for this dissertation concentrates on developing mathematical models of drug delivery to
solid tumors, including a discrete model of angiogenesis used to create a capillary network
model of microvasculature. This network is then used in a fluid flow model to couple
intravascular and extravascular flow. This fluid flow model captures key features that
occur in both tissue and microvasculature. Using this model, the important factors in
both angiogenesis and drug delivery are investigated. This dissertation is organized in the
following manner.
Chapter 2 provides a general model of interstitial fluid flow in both cancerous and nor-
mal tissues. Instead of representing a discrete and heterogeneous vasculature, a continuous
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and homogenized source term is considered throughout the tissue. This chapter provides
a background to the biological and physiological characteristics of cancerous tissues and
highlights the complexity of transport phenomena in a solid tumor, even for a more spe-
cific geometry (spherical shape) and uniform distribution of microvessels. Also included
is a discussion of the importance of two new parameters introduced in this dissertation.
Certain key features of those two new parameters conclude the chapter. Results presented
in Chapter 2 have already been published in PLoS ONE [92].
Chapter 3 presents of an overview of tumor shape and size effects on drug delivery to
solid tumors. These effects are established by application of the governing equations for
fluid flow, i.e., the conservation laws for mass and momentum, to physiological systems
containing solid tumors, under an assumption that drug particles flow with the interstitial
fluid. Drug delivery problems have been most extensively researched in spherical tumors,
which have been the simplest to examine with analytical methods. With our numerical
method introduced in Chapters 2 and 3, however, more complex tumor shapes can be
studied. The numerical model of fluid flow in solid tumors previously introduced by our
group is further developed to incorporate and investigate non-spherical tumors such as
prolate and oblate ones. The chapter also explores the effects of the surface area per
unit volume of the tissue, vascular and interstitial hydraulic conductivity on drug delivery.
Results presented in Chapter 3 have already been published in the Journal of Biological
Engineering [93].
Cancer invasion and metastasis rely on tumor-induced angiogenesis, the formation of
new blood vessels from existing vasculature in response to tumor angiogenic factors. An-
giogenesis is a complicated phenomenon including even more complex interactions such as
cell-cell and cell-matrix communication. The details of processes required for angiogene-
sis to occur and also details of modifications of some features of the previously presented
continuous and discrete models of angiogenesis are discussed in Chapter 4. These modifi-
cations are on the initial distribution of fibronectin and tumor angiogenic factor (TAF) in
the domain and also in the interpretation of the effect of matrix degrading enzyme (MDE)
in the continuous and discrete model. One of the main advantages of this study is the
realistic movement probability distribution achieved. Capillaries should accelerate as they
move toward the tumor, a phenomenon not reflected in previous modeling. Here, changing
the function of the chemotactic coefficient and also real initial conditions leads to more
realistic movement probability distribution in the domain; thus, capillaries demonstrate an
increased probability to move toward the tumor as they approach a tumor. Fibronectin
degradation is clearly shown to establish haptotactic movement, and in the absence of
MDE, the expected haptotactic movement decreases. Results presented in Chapter 4 have
already been submitted to a scientific journal.
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To date, microvasculature flow modeling has been most extensively studied with simple
tumor shapes and their microvessels at different levels and scales. However, with our
numerical model proposed in Chapter 5, more complex and realistic tumor shapes and
capillary networks can be studied. This chapter formulates a fluid flow model of blood in
a capillary network model of a solid tumor and its surrounding tissue. First, governing
equations of angiogenesis are implemented to specify the different domains for the network
and interstitium. Once the initial and boundary conditions are set, the discretized form of
the governing equations for the capillary network can be solved. Then, fluid flow equations
are introduced for different domains. A comprehensive continuum mathematical model
of interstitial fluid flow in a solid tumor has already been developed for physiological
systems containing solid tumors in Chapters 2 and 3. As introduced in these chapters,
this model is based on the governing equations for fluid flow, i.e., the conservation laws for
mass and momentum, and Darcy’s equation. The equations governing blood flow through
capillaries are the Navier-Stokes equations that are simplified to the Poiseuille equation
for this study. Starling’s law closes this system of equations and couples the intravascular
and extravascular flows. Using an element-based finite volume numerical method, the
discretized form of the governing equations, with appropriate boundary conditions, has
been developed to calculate the interstitial fluid and intravascular pressures.
Also in Chapter 5, in order to show the effect of individual vessels in normal and
cancerous tissues instead of having a uniform and continuous distribution of microvessels
such as those used in Chapters 2 and 3, a capillary network model introduced in Chapter
4 is considered because it gives a more realistic distribution of microvessels, one very close
to that in the human body. After setting up the capillary network, a mass conservation
equation must be applied at each node for intravascular flow, as in any other network flow
model. This is the first study to naturalistically couple intravascular and extravascular flow
through a loop made of a parent vessel connected to the network. That is, the same vessel
runs to and from the network and engages in that network, in contrast to the situations
portrayed in other studies that unrealistically consider veins and arteries to operate on
opposite sides of a tumor network. For intravascular flow, this study considers the effect
of viscosity dependency on hematocrit and vessel diameter. Vessel adaptation and phase
separation are also considered in this work for intravascular flow. All of these assumptions
are added to previous models in the hope of more realistic results. Results presented in
Chapter 5 have already been submitted to a scientific journal.
3
1.1 Objectives
Numerical simulation provides a good understanding of the mechanism of drug delivery
and is also very instructive to show some of the major barriers in this process of drug
delivery to solid tumors. For instance, one can find an optimum schedule of treatments
based on the different values of simulation parameters. To design an optimum mechanism
for drug delivery, the transport mechanisms and their obstacles have to be clarified, which
was one of the main objectives of this research.
The main goal of this study was to simulate drug delivery to solid tumor microvascu-
lature. To cover the following parts missing from the literature, the specific objectives of
this study were as follows:
• Study the effect of the size, shape and physical properties of solid tumors,
• Improve the previous model to include nanoparticle drug delivery,
• Include the heterogeneity and discontinuous form of blood vessels in the model,
• Solve the governing equations simultaneously as a multi-scale problem,
• Study the capillary network model of tumor-induced angiogenesis for both continuous
and discrete models,
• Study fluid flow models for different models of microvessels such as uniform, non-
uniform, and network-based, and finally,




Numerical Modeling of Fluid Flow in
Solid Tumors
2.1 Introduction
Cancer is the second leading cause of death, today causing one of every four deaths in North
America [43]. Although the most important treatment is surgical removal of tumors, the
key to a successful cure is often an efficient delivery of anticancer drugs after the surgery.
Many new drugs have been developed to eradicate cancer but are ineffective when used
in humans for lack of efficient delivery. Moreover, all drugs have possible side effects,
such as toxicity to normal cells and the development of drug resistance [49]. Residual
tumor cells and re-growth of tumors are common sequels to the use of most of these drugs.
The drugs’ most noticeable limitation is their inability to reach a targeted area without
affecting healthy tissues or cells. The two considerations in effective cancer treatment, from
an engineering point of view, are drug transport and drug conversion or reaction at the
tumor site [7, 45]. Many drugs cannot be delivered to their targets because of transport
limitations. Other drugs induce biochemical reactions in the body that produce toxicity.
It is known that more than 85% of human cancers involve solid tumors, and current
chemotherapy depends on the adequate delivery of therapeutic agents to tumor sites [43].
It is also well recognized that the blood supply to a solid tumor is highly heterogeneous
[46, 40]. Although small drugs such as taxol distribute pretty well in tumor tissue as
they can diffuse and do not rely on convection, larger drugs behave differently. In fact,
for large particles such as antibodies, drug concentration is highest closest to vasculature,
well-perfused areas, and on the peripheral walls of the tumor, but very low or no drug
5
reaches 90% of the tumor [51, 87]. However, for successful cancer treatment, all areas of
the tumor must be exposed to chemotherapy agents; otherwise, the tumor will eventually
regrow [34].
According to clinical research findings, even though drug delivery through systemic
administration may inhibit tumor growth, most drug treatments fail to eliminate malignant
tumors completely [12]. Some experimental and computational investigations show that
systemic administration cannot distribute drugs uniformly in tumors. Baxter et al. have
shown that, in addition to blood flow heterogeneities and impeded interstitial transport,
another mechanism effectively contributes to the non-uniform distribution of drugs: high
interstitial pressure in solid tumors [38, 39, 44]. There are two important effects of this
high interstitial pressure, and both limit transport in solid tumors. These two effects
are illustrated schematically in Figure 2.1. The first is a decrease in driving force for
transcapillary exchange of fluid and therefore drugs. This effect is highlighted in Figure 2.1.
Low filtration occurs at the center of the tumor as a result of the high interstitial pressure,
and high filtration occurs at the periphery of the tumor as a result of the low interstitial
pressure. The second effect is a radially outward convective flux in the interstitium as
fluid flows towards the outer layers of the tumor. This effect is illustrated in Figure 2.1 as
an outward convection due to pressure gradient. The value of the radially outward fluid
velocity at the tumor rim for a tumor with a 1cm radius, 4.2g, is 0.1 ∼ 0.2µm/s [7]. Another
important process in drug delivery is indicated in this schematic as an inward diffusion due
to concentration gradient of the drug. Effective penetration into a solid tumor requires
that the velocity of the diffusion process be higher than that of the convection process
[41]. On the other hand, uniformly distributed high interstitial pressure in the center of
a tumor blocks convection and, consequently, causes the heterogeneous perfusion of blood
into the center of tumors, resulting in the heterogeneous distribution of the drug [44]. The
existence of pressure gradients in tumors was discovered by Baxter et al. and confirmed by
Boucher et al. [13]. Baxter and Jain, using their theoretical framework, further found that
the drug diffusivity, pressure and velocity of interstitial fluids, vascular permeability and
lymphatic drainage are important factors in determining the drug concentration in tumors
[7, 8, 9]. Netti et al. showed that interstitial fluid pressure (IFP) depends on microvascular
pressure and blood flow within tumors [67].
Extending the one-dimensional models of Baxter and Jain [7, 8, 9] and Saltzman and
Radomsky [85] to a three-dimensional geometry, Wang et al. [103, 99, 33, 101, 100, 104]
developed a simulation framework of drug delivery to tumors. They considered high in-
terstitial pressure in tumors [44], the consequences of blood and lymphatic drainage, and
the chemical reaction of drug with the tissue. The main focus of their work was on using
diffusion-convection kinetics to improve simulation result accuracy. They showed that the
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Figure 2.1: Cross sectional schematic of a solid tumor that shows the three different regions
of a solid tumor, IFP distribution, drug concentration and filtration distribution from blood
vessels.
in vitro release profile of the drug from controlled release devices can be combined with
state-of-the-art computational fluid dynamics (CFD) simulations to predict drug delivery
behavior, both temporally and spatially, in both normal and cancerous tissues. The focus of
their work was the mathematical modeling of the drug release from polymer implants that
have certain characteristics of release profile. By applying sensitivity analysis, Zhao et al.
[115] determined the effect of spatially changing tissue transport properties on interstitial
fluid (including drug particles) transport.
Knowledge of tumor modeling has recently been expanded to include spatial and tem-
poral changes in blood flow by considering capillary network or single vessel approaches
[75, 19]. Before Baxter et al. [7, 8, 9] introduced their innovative model of interstitial
pressure as a function of tumor radius, little was known about tumor modeling, except
that interstitial pressure was highest at the center of a tumor [105] and that pressure is
directly proportional to tumor size [111, 105]. The promising combined therapies such as
radiotherapy and antiangiogenic therapy in addition to chemotherapy in tumor treatment
are good examples that can show the crucial role of the modeling. For example, computa-
tional fluid dynamics modeling results can be applied to optimize the interaction effect of
irradiation to the drug delivery efficiency.
The main focus of future drug delivery modeling will be on drug transport in tissues
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after drug release using either systemic administration or implantation mechanisms. Mod-
eling drug delivery involves different processes such as drug diffusion, convective transport
in extracellular matrices, drug extravasation from blood vessels, tissue elimination by the
lymphatic system, and intracellular internalization. In all of these processes, CFD can
play a crucial role. To clarify the mechanisms of drug delivery from the injection site to
absorption by a solid tumor, computational fluid dynamics has shown promise. So far,
drug delivery problems have been most extensively studied with spherical tumors, the sim-
plest to examine with analytical methods. With our proposed numerical method, however,
more complex shapes of tumor can be studied. Numerical simulations provide a detailed
understanding of the mechanisms of interstitial fluid transport and are also instructive to
show some of the major barriers to drug delivery to solid tumors. With this knowledge,
one can find, for example, an optimum schedule of drug treatment based on the simulation
results. To design an optimum scheme for drug delivery, the transport mechanisms and
their obstacles have to be clarified, which is one of the main objectives of this study.
The proposed CFD model is made for a spherical tumor and its surrounding normal
tissue. However, this model can be extended to study non-spherical tumors, especially if
its geometries are reconstructed from high-resolution images. Grid generation divides the
whole domain or geometry into finite volumes, called meshes. Tetrahedral elements can be
used to handle non-spherical tumors. The tumor and its surrounding tissue are assumed to
be rigid porous media. The vasculature as a source term varies spatially. Interstitial fluid
flow equations in porous media are solved using a CFD code that employs unstructured
grids. In studying interstitial fluid pressure distribution, the numerical method, which
introduces two critical parameters (tumor radius and necrotic radius), is more effective
than the analytical method.
2.2 Drug Transport within Solid Tumors
Fluid seeps slowly but constantly from blood vessels into surrounding tissues in most
normal tissues. The lymphatic system then reabsorbs this lost fluid and returns it to the
blood stream. However, no such lymphatic drainage system for solid tumors has been
reported in the literature [7, 45]. Computer simulations show that this lack of lymphatic
system involvement may result in a buildup of interstitial pressure, leading to cessation of
the usual blood seepage from vessels. As a consequence, large molecules (including cancer-
fighting drugs) cannot be carried out of vessels to interact with tissue. Thus, cancer drugs
cannot reach the tumor site.
Some drug particles, such as Monoclonal Antibodies (MAbs), are relatively large and
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move very slowly within tissues [7]. To be effective, these large anticancer agents have to
cross the blood vessel wall, traverse the interstitial space that contains the cancer cells,
bind to the cancer cell membranes and, if the target is intracellular, penetrate the cancer
cell membranes.
Tissue spaces are made up of three parts, all of which are relevant to the delivery
of drugs to tumors: the vascular, the interstitial, and the cellular. The vascular space
comprises the blood vessels, arteries, arterioles, capillaries, venules, and veins [16]. The
interstitial space, a gel-like region between blood vessels and cells, is filled with fibers such
as collagen, and gives structural stability, glycosaminoglycans (GAG), and other proteins.
The cellular space includes specific tissue cells (cancer cells in a solid tumor), in addition
to other cells, such as pericytes, macrophages, and fibroblasts [7, 8, 9].
2.3 Mathematical Model of Interstitial Fluid Trans-
port
The distribution of vasculature and cells in solid tumors is spatially heterogeneous. In
the center of solid tumors, there is a necrotic core where most of the cells are dead. The
outer boundary of solid tumors contains many exchange vessels, a large blood supply,
and fast-dividing cells. Therefore, the mathematical model should be accurate enough to
include the dependency of physiological parameters, such as hydraulic conductivity, on
space; that is, it must be able to clearly represent all the physical variations in a tumor.
Nevertheless, because the time scale of transport phenomena is much less than that of
tumor growth, the physiological parameters can be considered time independent [7]. For
the sake of simplicity, solid tumors are considered here to be spherical. In a macroscopic
model, only the distribution of variables, such as interstitial pressure and concentration,
over the length scale of the tumor radius is important, and microscopic characteristics, such
as blood vessels, cells, and the interstitial matrix, are not involved directly in the model.
Comparison of the tumor radius, on the order of magnitude of 1cm, O(1cm), with the
intercapillary distance (the average distance between two capillaries), O(100µm), indicates
that variations over microscopic length scales can be averaged out [84]. The screening
length,
√
µk (in which µ and k are the viscosity of the interstitial fluid and the hydraulic
conductivity of the interstitium, respectively), is on the order of 60Å; therefore, the fluid
transport in the tumor interstitium can be described by Darcy’s law for flow through a
porous medium [84, 45, 88, 35, 25, 10]:
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where k[cm2/mmHg s], Pi[mmHg], v[m/s] and r[cm] are the hydraulic conductivity of
the interstitium, the interstitial fluid pressure, the interstitial fluid velocity and the radial
position, respectively. In the case of anisotropic and heterogeneous porous media, k is a
tensor and function of the location in the medium. There are some limitations to the use of
Darcy’s law. For instance, it is not applicable for non-Newtonian fluids, Newtonian fluids
at high velocities, or for gases at very low or very high velocities. It is also shown that the
friction within the fluid and exchange of momentum between the fluid and solid phases are
neglected by Darcy’s law. Fortunately, in the interstitium of biological tissues, all these
exceptional cases are rare (most of the phenomena are low velocity for Newtonian fluids)
except for the friction within the fluid; therefore, Darcy’s law is quite applicable to the
analysis of interstitial fluid flow.
The mass balance equation for a steady state incompressible fluid is that the divergence
of the fluid is zero, or mathematically,
∇ · v = 0 (2.2)
The same equation is also applicable in porous media if there is no fluid source or fluid
sink in the medium. However, in most biological tissues, sources and sinks are present.
For instance, between interstitial space and the blood or lymph vessels, fluid is exchanged;
therefore, the steady state incompressible form of the continuity equation must be modified
as
∇ · v = φB(r)− φL(r) (2.3)
where v is the fluid velocity in the representative elementary volume (REV). The continuity
equation can also be written as
∇ · (εvf ) =
{
φB(r)− φL(r) for r ≥ Rn
0 for r < Rn
(2.4)
where Rn[cm], ε, vf [ms
−1], φB(r)[s
−1], and φL(r)[s
−1] are the radius of the necrotic core,
the porosity or the volume fraction of fluid, the fluid velocity averaged in the volume of fluid
phase, the fluid source term, and the lymphatic drainage term, respectively. In biological
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tissues, the two last terms signify the rate of fluid flow per unit volume from blood vessels
into the interstitial space and from the interstitial space into lymph vessels, respectively.
Both rates can be evaluated through Starling’s law. It should be noted that Equation
2.4 in this general form is applicable to any kind of biological tissue, whether normal or
cancerous. In dead tissues, with no flow in the blood or lymph vessels, the value for both







(PB − Pi − σs(πB − πi)) (2.5)
The parameters used in Equation 2.5 are: JV
V
[s−1] , volumetric flow rate out of the vascula-
ture per unit volume of tissue; S
V




], hydraulic conductivity of the microvascular wall; PB[mmHg], vascular
pressure; σs, average osmotic reflection coefficient for plasma proteins; πB[mmHg], osmotic
pressure of the plasma; and πi[mmHg], osmotic pressure of the interstitial fluid. Different
types of pressure used in Equation 2.5 are shown in Figure 2.2. It should be noted that the








(Pi − PL) for r ≥ Rn
φB(r) = φL(r) = 0 for r < Rn
(2.6)
The parameters used in these equations are: JL
V




], hydraulic conductivity of the lymphatic wall; and PL[mmHg], hydrostatic
pressure of the lymphatics.
Combination of Darcy’s law and the continuity equation results in
−∇ · k∇Pi = φB(r)− φL(r) (2.7)
For a very special case, when k is constant and there are no sinks and sources (for
example, in the necrotic core), the interstitial pressure can be expressed by the very well-
known Laplace equation.
∇2Pi = 0 (2.8)
If all parameters except Pi are assumed to be constant, substituting Equations 2.5 and
2.6 in Equation 2.7 results in
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(PB − Pi − σs(πB − πi))−
LPLSL
V
(Pi − PL) (2.9)




(Pi − Pss) (2.10)
PSS is defined later by Equation 2.14. Using the definition of the Laplace operator,
Equation 2.11, in the spherical coordinate system, Equation 2.10 is written as Equation
2.12.





































(Pi − Pss) (2.12)
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in Equations 2.10 and 2.12, the ratio of interstitial resistance to vascular resistance is
introduced in terms of α, the dimensionless parameter defined by Equation (2.13).
α = R
√
(LPS + LPLSL)/kV (2.13)
PSS = (LPSPe + LPLSLPL)/(LPS + LPLSL) (2.14)
The steady state pressure, PSS, is the interstitial pressure at which the efflux from
the vasculature and influx into the lymphatics are equal, and is defined by Equation 2.14.
Effective pressure, Pe, in Equation 2.14, is a parameter defined by vascular pressure, plasma
osmotic pressure, and interstitial osmotic pressure through Equation 2.15.
Pe = PB − σs(πB − πi) (2.15)
Applying the appropriate boundary conditions and also all the constants mentioned
earlier, the governing equation, Equation 2.10 or 2.12, can be used to calculate the in-
terstitial fluid velocity (IFV) and interstitial fluid pressure (IFP) profiles in solid tumors.


















in which the interstitial pressure that yields zero net volume flux out of the vasculature
is called the effective pressure, Pe, Equation 2.15. The steady state pressure and effective
pressure in solid tumors with no lymph vessels are the same. If Pi = Pe, no exchange of
fluid occurs between the interstitial space and blood vessels.
Due to symmetry, there is a no flux boundary condition at the center of the tumor; i.e.,
∇Pi = 0 or
∂Pi
∂r
= 0 for r = 0 (2.18)
At the outer edge of the solid tumor, r = R, two types of boundary conditions are
possible. In the first type, where the pressure in the surrounding tissue is fixed, the tumor
pressure at the outer edge is the same as the surrounding pressure, Psur.
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Pi = Psur for r = R (2.19)
This condition is applicable for an isolated tumor [36, 14]. In the second type, the solid
tumor is surrounded by normal tissues. Pressure decreases smoothly over a distance;
therefore, the continuity of pressure and velocity should be considered as an appropriate












Pi|R− = Pi|R+ (2.21)
where R− and R+ indicate the tumor and normal tissue radius at the outer edge of the
solid tumor; kt and kn are the hydraulic conductivity of the interstitium in tumor and
normal tissues, respectively. It should be noted that, in the second type, all the equations
mentioned for the tumor tissue have to be solved for the normal tissue, as well. It is
clear that for the normal tissue, far enough from the solid tumor that the pressure is
constant, the first type of boundary condition, Equation 2.19, must be applied. These two
types of boundary conditions are shown in Figure 2.3. The solution now can be obtained
analytically or numerically to find the IFV and IFP profiles for each of the two boundary
conditions. Analytical solutions, based on Baxter et al. [7] and Jain et al. [45], for both IFV
and IFP distributions in case of an isolated solid tumor are shown in Figure 2.4 and Figure
2.5, respectively. In this work, the numerical method has been used. An element based
finite volume method (EB-FVM) is applied to discretize the equations. The EB-FVM has
the capability of the finite element method (FEM) in handling complex geometries and
also the sound physical-based properties of the finite volume method (FVM) [91]. The
discretized form of the governing equations, in their general form, is then linearized and
solved implicitly. The SIMPLE (Semi Implicit Method for Pressure Linked Equations)
algorithm is used as the coupling method for pressure and velocity terms. Finally, the
converged form of the solution is calculated using an iterative method. In order to improve
the convergence rate, the method of successive over-relaxation (SOR) is applied with an
under relaxation factor equal to 0.75. The criterion for the convergence is to reduce the
residual by 6 orders of magnitude. In order to check the grid independency of the code,
the results for three different grids are compared, indicating the conservative property of
the numerical method. Final choice of the grid includes 11904 control volumes.
The material properties for tumor and normal tissue were taken from the simulation
studies of Jain and Baxter [44] and are shown in Table 2.1. It should be noted that tissue
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Figure 2.3: Two types of boundary conditions at the outer edge of the tissue
properties vary greatly among different organs for both normal and cancerous tissues;
therefore, the parameters introduced in Table 2.1 should be updated for new applications.
As mentioned earlier, tissue transport properties are often anisotropic. Geometric and
physiological properties of anisotropic and heterogeneous tissues affect drug delivery. This
issue can be solved with the help of diffusion tensor imaging (DTI). A good application of
this method in brain tumors is discussed by Linninger et al. [59].
2.4 Results
Figure 2.6 shows the unidirectional interstitial fluid velocity distribution in an isolated
solid tumor as a function of the dimensionless radius. This figure shows that the higher
the value of α is, the steeper the velocity profiles will be.
Figure 2.7 shows the unidirectional interstitial fluid pressure distribution in an isolated
solid tumor as a function of the dimensionless radius. Low values of α corresponding to
flat curves show less resistance to fluid source, but high values of α corresponding to sharp
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Figure 2.4: Interstitial velocity distribution in a 1 cm radius tumor, different values of α,
Baxter et al. [7] and Jain et al. [45]
Figure 2.5: Dimensionless interstitial pressure distribution in the same tumor, different
values of α, Baxter et al. [7] and Jain et al. [45]
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Table 2.1: Material properties used in numerical simulations, as taken from [44]
Parameter Tissue Baseline value Reference
Lp[cm/mmHg s] Normal 0.36× 10−7 Rippe et al. (1978)
Tumor 2.80× 10−7 Jain (1987a)
k[cm2/mmHg s] Normal 8.53× 10−9 Swabb et al. (1974)
Tumor 4.13× 10−8 Jain (1987a)
S/V [cm−1] Normal 70 Pappenheimer et al. (1951)
Tumor 200 Hilmas and Gilette (1974)
PB[mmHg] Both 15.6 Brace and Guyton (1977)
πB[mmHg] Both 20 Brace and Guyton (1977)
πi[mmHg] Normal 10 Wiederhielm (1979)
Tumor 15 Jain (1987a)
σs Normal 0.91 Ballard and perl (1978)
Tumor 0.82 Curry (1984)
curves in the periphery of the tumor show greater resistance to fluid source, based on the
definition of dimensionless parameter α.
Figure 2.8 shows IFP distribution based on the parameters’ values introduced in Table
2.1, which results in α = 36.8. Experiments done by Baxter et al. were based on this value
of α [7].
A three-dimensional plot of Figure 2.8, dimensionless interstitial pressure distribution,
is shown in Figure 2.9. All of these results agree well with experimental data [7, 38, 45].
Figure 2.10 shows the comparison of the current paper with experimental data (mam-
mary adenocarcinoma s.c.) by Boucher et al. [13]. In this figure there is good agreement
between model and experiment. Figures 2.11 and 2.12 show the IFV and IFP distribution
for a solid tumor embedded in normal tissue as a function of the dimensionless radius,
respectively. As mentioned earlier, boundary conditions for this case are different from
those of an isolated tumor and are stated in Equations 2.20 and 2.21.
Figure 2.13 shows the interstitial pressure distribution in a 1cm radius tumor, as a
function of a dimensionless radius for different values of necrotic radii. This figure shows
that an increase in the necrotic radius decreases the maximum pressure inside the tumor,
and obviously, when the entire tumor is necrotic, with no vasculature, the IFP is zero. On
the other hand, for a necrotic radius below a certain size, IFP approaches to its maximum
value, which is the effective pressure, Pe, and this limited size, which can be considered
as a critical necrotic radius or Rnc, can be interpolated from a graph such as Figure 2.14.
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Figure 2.6: Interstitial velocity distribution in a 1 cm radius tumor, different values of α,
Equation 2.16
Figure 2.7: Dimensionless interstitial pressure distribution in the same tumor, different
values of α
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Figure 2.8: Interstitial pressure distribution in the same tumor (α = 36.8)
Figure 2.9: Three dimensional plot of Figure 2.8, dimensionless interstitial pressure distri-
bution, in the same tumor (α = 36.8)
19
Figure 2.10: Comparison of the current study with experimental data (Mammary Adeno-
carcinoma s.c.) by Boucher et al. [13]
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Figure 2.11: Interstitial velocity distribution in a 1.4cm radius tumor and normal tissue
Figure 2.12: Interstitial pressure distribution in a 1.4cm radius tumor and normal tissue
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Figure 2.13: Interstitial pressure distribution in a 1cm radius tumor, as a function of the
dimensionless radius for different necrotic radii
The same graph for all sizes of solid tumors studied in this paper is also shown in Figure
2.15. From this figure, for instance, for tumors below a certain size (in this case 0.1cm),
reaching effective pressure, even with a zero value for their necrotic radius, is not possible.
Figures 2.16 to 2.18 show the same parameters as Figure 2.13 for the other three tumor
sizes, which follow the same behavior as explained for Figure 2.13.
2.5 Discussion
The calculated value of IFV for the periphery of an isolated tumor, shown in Figure
2.6, is on the order of 10−7m/s, a finding that agrees well with experimental data in
the literature [7, 38, 45, 14]. These results predict that the fluid filtration is negligible
throughout most part of the tumor and occurs mostly from vessels in the periphery, a well
vascularized region. Interstitial fluid pressure distribution for different values of α and
different boundary conditions, Figures 2.7 and 2.12, shows that IFP is elevated throughout
the tumor and goes down sharply in the periphery of an isolated tumor or at the normal
tissue around an embedded solid tumor. The immediate result of this high IFP is decreasing
blood flow and therefore insufficient delivery of drug. This general trend for IFP leads to
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Figure 2.14: Interstitial pressure distribution at the center of a 1cm radius tumor, as a
function of the dimensionless necrotic radius
Figure 2.15: Interstitial pressure distribution at the center of different tumors, as a function
of the dimensionless necrotic radius
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Figure 2.16: Interstitial pressure distribution in a 0.5cm radius tumor, as a function of the
dimensionless radius for different necrotic radii
Figure 2.17: Interstitial pressure distribution in a 0.25cm radius tumor, as a function of
the dimensionless radius for different necrotic radii
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Figure 2.18: Interstitial pressure distribution in a 0.1cm radius tumor, as a function of the
dimensionless radius for different necrotic radii
low drug filtration from blood vessels in the center of the tumor and high drug filtration
in the tumor periphery, as shown in Figure 2.1. On the other hand, the large pressure
gradient results in an outward convective flow that washes out the drug extravasated from
blood vessels at the tumor periphery. All of these phenomena are indicated in Figure 2.1,
schematically. In both cases, embedded and isolated tumor, IFP approaches Pe, effective
pressure, in the center of the tumor where the fluid source is minimal, as shown in Figures
2.7 and 2.12. On the other hand, in the periphery, the opposite scenario occurs; there is
minimum pressure and maximum fluid source. Based on the results of this study, drug
delivery can be enhanced by decreasing IFP in the center of the tumor. This may not be
easy to do, but there are some physical and enzymatic methods which can be applied. For
instance, blocking the integrin links between an interstitial matrix and cells decreases IFP
and enhances tissue fluid content. Also, irradiation by remodeling the extracellular matrix
decreases IFP in solid tumors [68]. Comparing IFP distribution in tumors with different
radii shows that IFP increases with tumor size. This study introduces two new parameters,
the critical tumor radius and critical necrotic radius. For tumors below the critical tumor
radius, the maximum interstitial fluid pressure is less than the effective pressure, no matter
what the value of the necrotic radius is. In fact, the transport of the drug to the center
of smaller tumors is much easier than transport to the center of a tumor whose radius is
greater than the critical tumor radius, as the maximum IFP is much lower than effective
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pressure, Pe. This study also shows that there is a critical necrotic radius, below which the
interstitial fluid pressure at the center of the tumor approaches to its maximum value. If
the tumor radius is greater than the critical tumor radius, this maximum pressure is equal
to the effective pressure.
2.6 Conclusions
Numerical solutions for the simplest case of a homogeneous and alymphatic tumor demon-
strate that, in a uniformly perfused tumor, high interstitial pressure is the main cause
of heterogeneous drug distribution. The main assumption used to reach this conclusion is
that drug particles flow with the interstitial fluid. The distribution of interstitial fluid pres-
sure and velocity have been calculated by numerical solutions to the governing equations.
Comparison of these numerical solutions and experimental data in the literature shows
that the maximum value for the interstitial pressure occurs at the center of the tumor and
decreases towards the periphery and that the numerical values of interstitial fluid velocity
and the experimental results reported in the literature agree. Interstitial fluid pressure is
not uniform whether the tumor vasculature is homogeneous or heterogeneous. Thus, in
addition to the heterogeneous distribution of blood supply, high interstitial pressure plays
a significant role in drug distribution in a solid tumor.
This study also shows that an increase in the necrotic radius decreases the maximum
pressure inside the tumor; the tumor that is completely necrotic has no vasculature, and
thus its interstitial fluid pressure is zero. This study introduces two new parameters,
the critical tumor radius and critical necrotic radius. Simulation results show that for
tumors below the critical tumor radius, the maximum interstitial fluid pressure is less than
effective pressure (a parameter determined by vascular pressure, plasma osmotic pressure,
and interstitial osmotic pressure); therefore, the transport of the drug to the center of
smaller tumors is much easier than transport to the center of a tumor whose radius is
greater than the critical tumor radius, as the maximum interstitial fluid pressure is much
lower than effective pressure. This study shows that there is a critical necrotic radius, below
which the interstitial fluid pressure at the center of the tumor approaches to its maximum
value. If the tumor radius is greater than the critical tumor radius, this maximum pressure
is equal to the effective pressure. Above this critical necrotic radius, the interstitial fluid
pressure at the center of the tumor is below effective pressure.
The numerical model investigated here can be further extended to apply to anisotropic
tissues in terms of properties and geometry. Capillary distribution in real tissues is hetero-
geneous and non-uniform. This numerical model can handle this issue as well. Microcir-
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culation studies show that for some drugs the relative size of nanoparticles is comparable
to the capillary diameter; therefore, flow field has to be modeled as a two-phase flow. The




Effect of Tumor Shape and Size on
Drug Delivery to Solid Tumors
3.1 Introduction
Cancer causes one in every four deaths in North America and is the second most common
cause of death worldwide [43]. Solid tumors account for 85% of human cancers [43]. Al-
though the most important cancer treatment is surgical removal of such tumors, the key
to a successful cure often involves efficient delivery of anticancer drugs to the tumor site
after the surgery. Many new drugs have been developed, but lack of an efficient means of
delivery makes them less effective. Moreover, some of these drugs induce biochemical re-
actions in the body that produce toxicity. Bioengineers are primarily concerned with both
the transport of drugs within the body (which usually involves systemic delivery through
the blood supply) and with biochemical reactions or conversions at tumor sites [7, 45].
All of these problems demonstrate that solutions to drug delivery limitations are urgently
needed [43].
Two factors inhibit the effective delivery of drugs within tumors: non-uniform blood
supply and non-uniform interstitial pressure distribution [46, 40]. Drugs concentrate most
readily in areas with the best blood supply. In solid tumors, these areas are closest to the
blood vessels (the vasculature) and a tumor’s peripheral walls; however, 90% of a tumor
receives little or no drug, meaning that treated tumors tend to regrow, as only their outer
cells have been killed by the drug [51, 87, 34, 12]. Variations in the interstitial (i.e., of
connective tissue in which cells are embedded) pressure, from its minimum value at the
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tumor surface to its maximum value at the tumor center, reduce fluid exchange (filtration
flux) and further inhibit the movement of the drug into the center of the tumor.
Previous research has shown that drugs administered systemically are not uniformly
reaching tumor sites. In addition to blood flow heterogeneities and impeded interstitial
transport, another mechanism effectively contributes to the non-uniform distribution of
drugs: high interstitial pressure in solid tumors [38, 39, 44]. High interstitial pressure
limits drug transport in two ways: 1) it reduces the driving force that is the result of
the interstitial fluid pressure and vascular pressure difference; 2) it moves fluid to the
outer layers of the tumor in which the interstitial pressure has its minimum. Both these
effects are shown schematically in Figure 3.1. The first effect decreases the driving force
for transcapillary exchange of fluid and, therefore, drugs. Low filtration (liquid source per
tissue volume) occurs at the center of the tumor as a result of the high interstitial pressure
or low driving force, and high filtration occurs at the periphery of the tumor as a result of
the low interstitial pressure or high driving force. The second effect of the high interstitial
pressure results in a radially outward convective flux in the interstitium as fluid flows
towards the outer layers of the tumor. This effect is illustrated in Figure 3.1 as an outward
convection due to interstitial fluid pressure gradient. The value of the radially outward
fluid velocity at the tumor rim for a solid tumor (mammary adenocarcinoma s.c.) with a
1cm radius, 4.2g , is 0.1 ∼ 0.2µm/s [7]. Figure 3.1 demonstrates another important feature
of drug delivery to tumors: an inward diffusion due to concentration gradient of the drug.
Effective penetration into a solid tumor requires that the velocity of the diffusion process
be more than that of the convection process [41]. On the other hand, uniformly distributed
high interstitial pressure in the center of a tumor results in heterogeneous distribution of
drugs [44].
Modeling drug delivery involves processes such as drug diffusion, convective transport
in extracellular matrices, drug extravasation from blood vessels, tissue elimination by the
lymphatic system, and intracellular internalization. In all of these processes, computa-
tional fluid dynamics (CFD) can play a crucial role in clarifying the mechanisms of drug
delivery from the injection site to absorption by a solid tumor. In-vitro release profiles of
systemically administered drugs have been combined with state of the art computational
fluid dynamics simulations to predict both temporal and spatial drug delivery in many
studies [103, 99, 33, 101, 100, 104]. Temporal and spatial changes in blood flow have also
been studied with a focus on capillary-network or single-vessels [75, 19]. The main focus
of future drug delivery modeling involves the transport of the drug in tissues after drug
release by either systemic administration or implantation.
As spherical tumors are the easiest to examine analytically, they have been used in
most studies. The effect of tumor shape has not been addressed in the literature except
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Figure 3.1: Cross sectional schematic of a solid tumor that shows the three different regions
of a solid tumor, IFP distribution, drug concentration and filtration distribution from blood
vessels [92]
the analytical study of by El-Kareh and Secomb [29]. The numerical method introduced
here allows modeling of more complex shapes and promotes a better understanding of the
complex mechanisms of interstitial fluid transport that effective drug delivery must depend
on. In studying tumor modeling, the numerical method, which introduces more features
of drug delivery to solid tumors, is more effective than the analytical method.
The proposed CFD model is made for both spherical and non-spherical tumors and
their surrounding normal tissues. This model can be further extended to study geometries
reconstructed from high resolution images. In this study the tumor and its surrounding
tissue are assumed to be rigid porous media. The vasculature as a source term varies
spatially. The grid generation divides the whole domain or geometry into finite volumes,
called meshes. Interstitial fluid flow equations in porous media are solved using a CFD
code (based on the proposed CFD model) that employs unstructured grids (tetrahedral
elements) to handle non-spherical tumors.
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3.2 Mathematical Model of Interstitial Fluid Trans-
port in General Form
The tissues most relevant to this discussion are the vasculature (vessels that, with the heart,
comprise the circulatory system that carries blood throughout the body), the interstitium
(or interstitial space), and the cells. Also relevant is the lymphatic system, which, simply
put, is responsible for tissue drainage. The vasculature system involves vessels (essentially
tube-like structures) of varying sizes, from the large arteries and veins down to the much
smaller arterioles, venules and capillaries [16]. The interstitium is formed of fibers such as
collagen, which gives structural stability, glycosaminoglycans (GAG), and other proteins.
Together, these fibers make up the gel-like region between blood vessels and cells. The
cells, occupying the cellular space, include specific tissue cells (i.e., the cancer cells of a solid
tumor) and others such as pericytes, macrophages, and fibroblasts not discussed in this
study [7, 8, 9]. In normal physiology, fluid seeps slowly but constantly from blood vessels
into the surrounding tissues. The lymphatic system then reabsorbs this lost fluid and
returns it to the blood stream. All the above tissues must be considered in any discussion
of drug delivery to tumors. Specifically, to be effective, drugs must cross the blood vessel
wall, traverse the interstitial space containing the cancer cells, and bind to and (if the
target is intracellular) penetrate the cancer cell membrane. The lymphatic system then
removes excess fluid and debris. However, a lack of such lymphatic drainage in solid tumors
has been reported in the literature [7, 45]. Computer simulations show that this lack of
lymphatic system involvement may result in a build up of interstitial pressure, leading to
cessation of the usual blood seepage from vessels. Consequently, large molecules cannot be
carried out of vessels to interact with tissue. As some drug particles, including Monoclonal
Antibodies (MAbs) used to fight cancer, are large and move very slowly within tissues,
they cannot reach the tumor site and are thus ineffective [7].
The mathematical model used for interstitial fluid transport has been described in the
previous Chapter in detail. To apply that model to different shapes of solid tumors, it is
necessary to work on a more general form of the governing equation.




(Pi − Pss) (3.1)





(Pi − Pss) (3.2)
which is the same as Equation 2.10.
PSS is defined later by Equation 3.6. Using the definition of the Laplace operator,
Equation 3.3, in the spherical coordinate system, Equation 3.2 is written as in Equation
3.4.





































(Pi − Pss) (3.4)
In Equations 3.2 and 3.4, the ratio of interstitial resistance to vascular resistance is
introduced in terms of α, the dimensionless parameter defined by Equation 3.5.
α = R
√
(LPS + LPLSL)/kV (3.5)
PSS = (LPSPe + LPLSLPL)/(LPS + LPLSL) (3.6)
The steady state pressure, PSS, is the interstitial pressure at which the efflux from
the vasculature and influx into the lymphatics are equal, and is defined by Equation 3.6.
Effective pressure, Pe, in Equation 3.6, is a parameter defined by vascular pressure, plasma
osmotic pressure, and interstitial osmotic pressure through Equation 3.7.
Pe = PB − σs(πB − πi) (3.7)
Applying the appropriate boundary conditions and also all the constants mentioned
earlier, the more general form of the governing equation, Equation 3.1, can be used to
calculate the interstitial fluid velocity (IFV) and interstitial fluid pressure (IFP) profiles in
solid tumors. Of note, for spherical solid tumors, simpler forms of the governing equation,
Equation 3.2 or 3.4, can be used. Additionally, α is a dimensionless constant used here for
convenience (only in spherical tumors); in general (arbitrary shapes), more fundamental
physical constants such as LP , S, LPL, SL, k, and V , used in Equation 3.1, should be used.
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in which the interstitial pressure that yields zero net volume flux out of the vasculature
is called the effective pressure, Pe, Equation 3.7. The steady state pressure and effective
pressure in solid tumors with no lymph vessels are the same. If Pi = Pe, no exchange of
fluid occurs between the interstitial space and blood vessels.
Due to symmetry, there is a no flux boundary condition at the center of the tumor; i.e.,
∇Pi = 0 or
∂Pi
∂r
= 0 for r = 0 (3.11)
At the outer edge of the solid tumor, (r = R for a spherical tumor), two types of
boundary conditions are possible. In the first type, where the pressure in the surrounding
tissue is fixed, the tumor pressure at the outer edge is the same as the surrounding pressure,
Psur.
Pi = Psur for outer region, r ∈ Ω (3.12)
This condition is applicable for an isolated tumor [36, 14]. In the second type, the
solid tumor is surrounded by normal tissues. Pressure decreases smoothly over a distance;
therefore, the continuity of pressure and velocity should be considered as an appropriate












Pi|Ω− = Pi|Ω+ (3.14)
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Figure 3.2: Two types of boundary conditions at the outer edge of the tissue [92]
where Ω− and Ω+ indicate the tumor and normal tissue at the outer edge of the solid tumor;
kt and kn are the hydraulic conductivity of the interstitium in tumor and normal tissues,
respectively. It should be noted that, in the second type, all the equations mentioned for
the tumor tissue have to be solved for the normal tissue as well. For the normal tissue,
far enough from the solid tumor that the pressure is constant, the first type of boundary
condition, Equation 3.12, must be applied. Figure 3.2 shows these two types of boundary
conditions. The solution can now be obtained analytically or numerically to find the
IFV and IFP profiles for each of the two boundary conditions. In this work, the same
numerical method explained in detail in Chapter 2 has been used. In order to check the
grid independency of the code, the largest tumor in this study is chosen and the results for
three different grids are compared, indicating the conservative property of the numerical
method. The final choice of the grid in this test case includes 11904 control volumes. For
other tumor geometries the same mesh parameters are applied.
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Figure 3.3: Different shapes of solid tumors: spherical, oblate, and prolate
3.3 Results
The actual tumor shape is not necessarily spherical. How to handle the patient’s specific
tumor and tissue dimensions in transport equations is discussed in the literature [51]. To
study different shapes of solid tumors – spherical, oblate (flattened), and prolate (elon-
gated) – shown in Figure 3.3, the governing equation is solved numerically [92]. Generally
speaking, it is believed that increasing the hydraulic conductivity of tumor vessels increases
the drug delivery to tumor cells. Many researchers, such as Sands et al. [87], Khawli et
al. [53], LeBerthon et al. [55], and Cope et al. [22], have stated the abovementioned
hypothesis and tried to explain their experimental results based on it.
Figure 3.4 shows the volumetric flow rate out of the vasculature per unit volume, also
called liquid source per tissue volume or filtration flux, at the different tumors’ centers as
a function of the multiplication of hydraulic conductivity of the microvascular wall and








(Pe − Pi) (3.15)
The parameters used in Equation 3.15 are JV
V
[s−1] , the volumetric flow rate out of the
vasculature per unit volume of tissue; S
V
[cm−1] , the surface area per unit volume for
transport in the tumor; Lp[
cm
mmHg s
] , the hydraulic conductivity of the microvascular wall;
Pe[mmHg] , the effective pressure; and Pi[mmHg] , the interstitial fluid pressure. All
parameters used to solve this equation are listed in Table 2.1.
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Figure 3.4: Liquid source (Volumetric flow rate out of the vasculature per unit volume
of tissue or filtration flux) per tissue volume at the tumors’ center, as a function of mul-
tiplication of hydraulic conductivity of the microvascular wall and surface area per unit
volume
Figure 3.4, shows that in a spherical solid tumor with a certain radius, R, if hydraulic
conductivity is increased, the volumetric flow rate first increases to reach an optimum value
(maximum) and then decreases. This graph also indicates that an increase in the diameter
of spherical solid tumors causes a decrease in the optimum value of the volumetric flow
rate. Decreasing one order of magnitude of tumor radius increases the volumetric flow rate
approximately two orders of magnitude. This optimum value occurs in response to a small
value of hydraulic conductivity in spherical solid tumors with a relatively larger diameter.
The values of hydraulic conductivity that result in optimum values of the flux are called
optimum values of hydraulic conductivity. The filtration flux (or the volumetric flow rate),
shown in Figure 3.4 as a function of LpS/V , indicates that the usual values for Lp or S/V
in the literature, listed in Table 2.1, are much greater than the optimum values shown in
this graph. Loptp , the optimum value of hydraulic conductivity, can be found easily in a
graph such as Figure 3.4 for different tumor sizes, or one can find the appropriate size for
a specific tumor tissue with a known value of Lp to have the maximum drug flow rate. In
Figure 3.4, Lp changes linearly from its minimum values to its maximum values. On the
other hand, the pressure difference (between effective pressure and IFP) changes from Pe
(when IFP is equal to zero) to zero (when IFP is equal to the effective pressure). When
Lp is at its minimum, the pressure difference is at its maximum, and vice versa. This
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Figure 3.5: Liquid source per tissue volume at the tumors’ center, as a function of surface
area per unit volume
circumstance results in a peak in the volumetric flow rate curve in terms of the hydraulic
conductivity of the microvascular wall, Lp, and surface area per unit volume, S/V , or a
combination of these factors through Equation 3.15.
Baxter et al. [44] stated that, with a decrease in the surface area of the tumor vascu-
lature, the amount of fluid filtered and therefore the amount of drug filtered decreases as
well. However, Figure 3.5 shows that this statement is true for just part of the curves. The
same behavior occurs for surface area per unit volume instead of hydraulic conductivity;
the graph showing this similarity is shown in Figure 3.5.
For most cancerous tissues, the hydraulic conductivity of the interstitium is not reported
accurately in the literature [29]. For those cases reported in the literature, such as recent
work of Linninger et al. [59] on estimating the hydraulic conductivity in porous brain tissue,
one can use inverse method and apply numerical method presented in this study to calculate
the hydraulic conductivity and compare it with the estimated value in [59]. However, the
change in k has been studied here, and the result, shown in Figure 3.6, indicates that k
and Lp have opposite effects on filtration flux. Figure 3.6 shows the behavior of volumetric
flow rate as a function of the hydraulic conductivity of the interstitium at the centers of
spherical tumors of different radii. This figure demonstrates that in smaller tumors (0.1cm
radius in this case) the maximum value of the volumetric flow rate occurs in a smaller
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Figure 3.6: Liquid source per tissue volume at tumors’ center, as a function of the hydraulic
conductivity of the interstitium
value of the hydraulic conductivity of the interstitium, at least two orders of magnitude
less than that of the larger tumor with a 1cm-sized radius. In fact, increasing the value
of k, decreases the amount of α. Low amounts of α result in low values of IFP. Based on
Equation 3.15, the effect of low IFP values is an increase in the volumetric flow rate.
Figure 3.7 shows that in a spherical solid tumor of a certain diameter, with an increase
in α, which is the dimensionless parameter defined based on Equation 3.10, the volumetric
flow rate increases first, but after reaching an optimum value (maximum), it decreases.
The interesting point about this graph is that the optimum values of the volumetric flow
rate for different sizes of spherical solid tumors occur at the same value of α. This figure
demonstrates that increasing one order of magnitude of tumor radius decreases the volu-
metric flow rate approximately two orders of magnitude at the same value of α2, almost
equal to 6. The simultaneous effect of effective pressure, Pe, and size is shown in Figure
3.8. The pattern for different sizes is the same; the more the effective pressure, the more
the volumetric flow rate. As discussed before [92] and shown in Figure 3.8, the lower the
tumor size, the lower the IFP, which results in a more volumetric flow rate.
Real tumors have unusual shapes. To show the effect of tumor shape and size on Pi
distribution and also the filtration flux for different values of Lp and S/V , the study in [29]
has been loosely reworked here but with a different approach in terms of formulation and
38
Figure 3.7: Liquid source per tissue volume at tumors’ center, as a function of α, a dimen-
sionless parameter
Figure 3.8: Liquid source per tissue volume at tumors’ center, as a function of effective
pressure
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Figure 3.9: Liquid source per tissue volume at the center of different tumor shapes with
the same volume as a spherical 0.1 cm radius tumor, as a function of multiplication of
hydraulic conductivity of the microvascular wall and surface area per unit volume
solution method to cover a greater variety of tumor shapes and sizes. As mentioned earlier,
the general form of the governing equation has been used in this Chapter to study non-
spherical solid tumors, shapes not covered in the literature. Figure 3.9 shows volumetric
flow rate behavior at the center of different tumor shapes that have the same volume as a
spherical 0.1cm radius tumor, as a function of multiplication of the hydraulic conductivity
of the microvascular wall and surface area per unit volume. Different colors show the
different values of λ (or a/b), the ratio of minor to major axes of both prolate and oblate
spheroids. Clearly, when λ is 1, all three shapes have become spherical. As is shown,
the general pattern for different shapes (spherical, prolate, and oblate solid tumors) is the
same. Rapid increase by the enhancement of hydraulic conductivity or surface area per
unit volume to an optimum value (maximum), and then the decrease by enhancement of
those parameters, is the main characteristic of Figures 3.9 to 3.12. Simultaneous effects
of shape and size of the tumors on the flux (volumetric flow rate) distribution can be
explained according to these four figures.
As the labels indicate, each figure is for a specific volume, which is the same for all
three shapes and is based on the size of spherical shapes. These figures show that although,
qualitatively, all three shapes have the same behavior, quantitatively, spherical and prolate
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Figure 3.10: Liquid source per tissue volume at the center of different tumor shapes with
the same volume as a spherical 0.25 cm radius tumor, as a function of multiplication of
hydraulic conductivity of the microvascular wall and surface area per unit volume
solid tumors are very much closer to each other in behavior than they are to that of oblate
solid tumors. This statement is truer for small tumors than larger ones and also for smaller
values of λ. As discussed, by increasing the radius of solid tumors, the order of volumetric
flow rate decreases, as through Figures 3.9 to 3.12. On the other hand, when λ approaches
one, all three shapes show the same behavior. Figure 3.13 shows the interstitial pressure
distribution at the tumor center for different values of λ (or a/b). It should be mentioned
that for each curve, the volume is constant, and Req is the radius of a spherical tumor
with the same volume as both prolate and oblate tumors. This figure indicates that, for
large tumors, except for extremely low values of a/b, which occur with very thin shapes
of tumors, the central pressure is independent of shape. This study also shows that there
are two limits for the central pressure value: for large tumors, Req > 0.25 cm, Pi ≈ Pe
(especially for prolate solid tumors), and for small tumors, Req < 0.02 cm, Pi ≈ Psur,
no matter what the shape of the tumor. For sizes between these two limits, for example
Req = 0.1 cm, as shown in Figure 3.13, the central pressure is a function of both tumor
shape and size. Thus, for 0.02 cm < Req < 0.25 cm, Psur < Pi < Pe.
Two limiting cases (in which a prolate spheroid approaches cylindrical geometry and
the oblate spheroid approaches a planar slab) are interesting to study with more detail.
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Figure 3.11: Liquid source per tissue volume at the center of different tumor shapes with
the same volume as a spherical 0.5 cm radius tumor, as a function of multiplication of
hydraulic conductivity of the microvascular wall and surface area per unit volume
These limiting cases can be achieved by choosing the very low values of λ (0.01 in this
case). The IFP distributions throughout these geometries for Req = 1.0 cm are shown in
Figure 3.14 to specify the effects of size and shape more carefully in these cases. This
figure shows that for non-spherical tumors, everything hinges on the smallest dimension,
and the other dimension is not important. When the smallest dimension of the prolate
tumor is close to or in a comparable size to the spherical one, the pressure distribution
is almost the same, as shown in Figure 3.14. For the oblate tumor, as the order of the
smallest dimension is very different from that of the spherical one, pressure distribution is
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Figure 3.12: Liquid source per tissue volume at the center of different tumor shapes with
the same volume as a spherical 1.0 cm radius tumor, as a function of multiplication of
hydraulic conductivity of the microvascular wall and surface area per unit volume
Figure 3.13: Pressure distribution at the center of different tumor shapes, as a function of
minor to major axes ratio. Req is the radius of a spherical tumor with the same volume as
both prolate and oblate tumors
43
Figure 3.14: Pressure distribution of different tumor shapes with the same volume as a
spherical 1.0 cm radius tumor, as a function of dimensionless length
totally different in Figure 3.14. The same figures as Figure 3.14 for other sizes of Req can
be shown here.
3.4 Discussion
The effect of increasing the hydraulic conductivity of microvessels, Lp, in terms of drug
delivery to solid tumors is significant to this discussion. There are two opposing phenomena:
the total fluid filtration flux for the whole solid tumor and local filtration within the solid
tumor; therefore, the liquid source term, the filtration flux at the center of the tumor,
has its highest value for an optimum value of Lp, as shown by El-Kareh and Secomb [29].
As they have shown in their study analytically, and is indicated here numerically, this
optimum value of Lp is a function of the size and shape of solid tumors. An increase in
Lp has a direct effect on the total rate and an opposite effect on the local filtration flux.
Increased vessel leakiness cannot result in more uniform drug distribution through tumors
much larger than 0.25cm.
Starling’s law shows that, because of low diffusivity, the dominant form of drug trans-
port through vessel walls (transvascular transport) is convection [29]. Based on Equation
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3.15, both hydraulic conductivity of the vessel wall and pressure difference across the wall
are effective in convective transport, again according to Starling’s law. Similar behavior is
true for S/V ; thus, an increase in Lp and S/V does not have a positive effect, and there are
optimum values for both of these parameters. However, the analysis of the work done in
[29], as well as this study, shows that, except when the nodule radius is smaller than 0.1cm,
the advantage of decreasing Pi is more important than that of decreasing the surface area.
As indicated, an increase in the hydraulic conductivity results in a volumetric flow
increase, but after a continued increase, volumetric flow approaches a certain value for all
different tumors. This pattern for tumors of all diameters is the same; the only difference
is that the smaller the tumor diameter, the sooner the leveling in volumetric flow.
The parameter α does not apply exactly in a non-spherical tumor; therefore, the general
form of the governing equation, different from the more specific form of that applied in
spherical solid tumors, has to be used here. This parameter, α, is a combination of other
fundamental variables such as hydraulic conductivity, which turns out to have a clean short
definition when solved for a sphere. This study shows that for a distinctly non-spherical
tumor (such as a prolate or oblate), everything hinges on the shortest dimension, and the
longer dimension is irrelevant, as any fluid or material flows to reach the closest surface.
Because El-Kareh et al. [29] used an analytical approach to solve the governing equa-
tions in prolate and oblate spheroidal shapes, they had to change the coordinate system
from a spherical one to a more complicated coordinate system, with oblate and prolate
spheroidal coordinates. In this coordinate system, the governing equation, the Helmholtz
equation, has a much more complicated form than the original equation. The solution for
this new form of equation is a Fourier series. In the work proposed here, the numerical
method is applied and, obviously the solution is not limited to any specific shape, offering
a freedom that is one of the main advantages of the numerical method over the previous
one.
3.5 Conclusions
The parameter α/R is independent of tumor geometry. It is a function of hydraulic con-
ductivity (an interstitial property) and vessel permeability. The main problem is defining
a characteristic length instead of R in non-spherical tumors. The pressure profile, however,
is a function of tumor geometry. Using a solution for IFP that was calculated assuming a
spherical profile will give a solution as a function of α, r, and R. Not surprisingly, equations
tailored to the different tumor shapes will yield different IFPs, as these pressures are the
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outcomes of the equations, and thus reflect the discrepancies. What will happen, whether
a tumor is a sphere or not, is that IFP will be approximately equal to the vascular pressure,
PB, throughout most of the interior. Only near the boundary, whether that boundary is
for a sphere or spheroid, will there be a steep pressure gradient as IFP falls to the pressure
of the surrounding tissue. For a very small radius, the differences will be significant. Above
the critical radius, shape is almost irrelevant.
This study shows that, as a rule, it is not true that the leakier the vessels, the higher
the value of convective transport of drugs to solid tumors. The results do show that only in
spherical solid tumors with a radius of less than 0.25cm, or in spheroidal ones with the same
volume, can drug convection be increased by making vessels more leaky. For spheroidal
shapes, the convection of drugs inside is higher than it is in spherical ones, and it seems
that for more irregular shapes, which are generally found in the body due to limitations
imposed by neighboring tissues and organs such as the brain, this effect is more marked.
For shapes studied in this paper, results show that the dependency of the maximized
flux (as a function of Lp and S/V or their multiplication) on size is much stronger than
its dependency on shape. It should be mentioned that due to very low diffusivity, the high
permeability of vessels cannot support homogeneous distribution inside tumors because
this high value results in more diffusive transport only in a narrow area around the vessels.
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Chapter 4
Effect of Matrix Density and Matrix
Degrading Enzymes in Continuous
and Discrete Mathematical Models of
Angiogenesis
4.1 Introduction
More than 85% of human cancers are in the form of solid tumors. The beginning of tumor
development is avascular, which means that the tumor obtains its required nutrients and
oxygen from the surrounding vasculature by diffusion. As the tumor gets larger, diffusion
alone cannot provide enough oxygen and nutrients. Consequently, the tumor stops its
growth and becomes dormant. The tumor is benign at this stage, and a complete cure
could be achieved by surgery. However, as a result of hypoxia, the tumor may be activated
again and start to secrete certain factors that induce nearby vessels to migrate toward the
tumor. This stage, which has a pivotal role in tumor growth, is called angiogenesis.
Angiogenesis, the formation of new capillaries from existing blood vessels, is the bridge
between the avascular and the fatal vascular tumor growth phases. Each cell in a mul-
ticellular organism has mechanisms to control its growth, proliferation, and death [62].
When these mechanisms are disrupted, the cell may undergo uncontrolled growth, leading
to cancer. After angiogenesis, the tumor has its own blood supply, which provides enough
oxygen and nutrients for further growth. In this stage, the tumor has vascular growth, and
its growth rate is much higher than that of the avascular phase.
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Angiogenesis is not limited to tumor development and is also observed in normal phys-
iological processes like embryogenesis and fetal development. The difference is that, in
the normal processes, it stops after accomplishing a general task such as wound healing,
or formation of an organ in embryogenesis. In contrast, in solid tumor development, the
process never stops.
Angiogenesis involves a cascade of events and many complicated processes. A com-
prehensive review and explanation of these process details are presented by Pawaletz and
Knierim [72] and Carmeliet and Jain [17].
Generally, the following steps take place during angiogenesis [72]
1. Formation of a hypoxic region in a tumor and secretion of angiogenic factors
2. Activation of endothelial cells (ECs)
3. Degradation of basement membrane
4. Formation of vessel sprouts
5. EC proliferation and migration
6. Vessel lumen formation
7. Fusing of the neighboring sprouts to form loops (anastomosis)
8. Blood circulation through the new vessels
9. Stabilization of vessels
In angiogenesis, ECs are activated by substances, called growth factors, secreted by the
tumor as a result of hypoxia, triggering a series of events:
1. Production of enzymes for degradation of the extracellular matrix (ECM)
2. Start of migration
3. Start of proliferation
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Once the angiogenic factors such as vascular endothelial growth factor (VEGF) and
basic fibroblast growth factor (bFGF) reach the ECs and bind to cell-surface receptors,
numerous changes start to happen in the internal machinery of the ECs, and they are
converted from a quiescent cell type to an active cell type that is able to migrate and
proliferate.
The finger-like protrusions of ECs created due to these changes degrade the basal lamina
adjacent to ECs and open the path for migration. In the initial steps of sprout formation,
the cells are recruited from parent vessels, but after some advancement of sprouts in the
ECM, the cells behind the tip cell start to proliferate. Matrix degrading enzymes (MDEs)
are produced by the ECs to degrade the ECM and open the path for sprout migration.
MDE is a general term representing numerous proteases that degrade different proteins
in the ECM. Two such proteases are the matrix metalloproteases (MMPs) and serine pro-
teases. MMPs are a group of MDEs that are able to degrade all ECM proteins. There
are more than 20 members in the MMP family, and they are identified by numbers and
classified according to their preferential substrate or similar structural domain. As in-
stances, collagenases, including MMP1, MMP8, and MMP13, are active against fibrillar
collagen; gelatinases, including MMP2 and MMP9, have high activity against denatured
collagens; and stromelysins, including MMP3, MMP10, and MMP11, act on non-collagen
components of the ECM.
Serine proteases are another family of proteases. One of the most important serine
proteases is the plasminogen activator-plasmin system. Plasmin is an activated form of the
plasminogen and is active against various ECM components like fibrin, collagen, laminin,
fibronectin, and proteoglycan.
The duty of proteases in the ECM is to facilitate EC movement. Two main mechanisms
for EC movement have been considered: chemotaxis and haptotaxis [18]. Chemotaxis and
haptotaxis are mainly responsible for EC migration toward tumors. Chemotaxis is the EC
movement due to gradients of tumor angiogenic factors (TAFs), and haptotaxis is directed
movement of EC toward adhesion gradients to components of the ECM like fibronectin.
It should be mentioned that for the purpose of modeling, a third mechanism, random
movement may be considered; however, it is not a physical movement mechanism and is
introduced only to facilitate EC movement in models.
Any interruption in these consecutive events may lead to unsuccessful angiogenesis.
This was the key idea presented by Folkman [30]. Prevention of angiogenesis can be ac-
complished in any possible state of its development, from production of tumor angiogenic
factors to prevention of their binding to the cell-surface receptors of ECs. Today, antian-
giogenic therapy is an accepted cancer therapy, although not used as the main method; it
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can benefit patients by supplementing chemotherapy or radiotherapy [52].
Mathematical Modeling is a developing tool in biological simulations like angiogenesis
modeling. In vivo and in vitro studies of angiogenesis are performed to observe tumor
development stages and also tumor and EC behavior during angiogenesis. The limited
number of assay systems and also difficulty in observing the details of successive angiogen-
esis events are drawbacks of in vivo studies; on the other hand, in vitro studies also have
problems. ECs in vivo experience shear stress and hemodynamic forces that affect their
behavior. ECs in vitro are cultured in mediums that are hyperoxic in comparison to in
vivo conditions. Moreover, interaction of ECs with other cell types in ECM such as smooth
muscle cells, perycites, etc., cannot easily be simulated in vitro [1]. In addition to these
two main methods of angiogenesis study, mathematical modeling, dating to the 1970s and
earlier, aims to help researchers in this field as a complementary method of investigation.
The complex nature of the process makes mathematical models difficult to apply. The huge
complexity of the process means that researchers must use complicated stochastic models
to predict the behavior of capillaries during network formation [71, 63, 113, 106, 6].
From a mathematical point of view, angiogenesis is a multiscale problem [83]. Intracel-
lular signal transduction leads to secretion of different factors and proteolytic enzymes. On
a cellular scale, the interaction between ECs and the ECM is of primary importance, and
on an extracellular scale, diffusion and distribution of angiogenic factors in the ECM should
be considered. Mathematical modeling on each of the above scales has been performed with
different approaches and levels of complexities. Mathematical modeling of angiogenesis,
if mature enough to consider essential requirements of the process, could help researchers
to predict the behavior of ECs and tumors under various conditions. Moreover, it could
provide significant help in the antiangiogenic therapy and drug delivery studies that are
among the main cancer research areas.
Mathematical models of angiogenesis can be categorized by three main modeling tech-
niques: continuous, discrete and hybrid [83], each involving several models and methods.
This work focuses on two specific continuous and discrete models. The continuous model
uses differential equations and is based on the mass conservation equation and chemical
kinetics. Cells are represented as continuous aggregates, without the necessity to consider
cells alone. This model gives overall good qualitative results but is not able to model the
morphological details of the sprouts during migration [4, 70].
The discrete method of angiogenesis modeling uses the same kind of equations as does
the continuous method but with different interpretation of the quantities [113, 4]. This
method is able to model the growth and motility of ECs. Morphological details of a
capillary network can be observed clearly in this model, and it can model branching and
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anastomosis during formation of the capillary network [98]. The advantages of this model
make it suitable for use in more-detailed models that consider flow and its effects on the
angiogenesis process [96, 97, 64].
The assumptions used in the continuous and discrete models of angiogenesis in previous
works need more investigation to exhibit the real physics of the problem. Moreover, the
effect of matrix density and its interaction with the MDE has not been observed in the
continuous and discrete models. Although MDE has been considered in some earlier studies
[97], its effect has not been shown separately to assess its importance and role in the models.
This current work does study the effect of MDE and matrix density on the continuous and
discrete models of angiogenesis. As well, using modifications to the equations for continuous
and discrete models, a model that implements real physical conditions is attempted.
This work, based on the model presented by Anderson and Chaplain [4] and used in
some subsequent works [96, 63, 15, 107], presents a model that includes the effect of matrix
density on capillary network formation. This effect was imposed on the model by including
a function in the movement potential term in the equations. The chemotaxis function
was also modified to make the capillaries accelerate as they get closer to the tumor. To
capture the real physics of the problem, we replaced the initial and boundary conditions
of the model presented by Anderson and Chaplain with certain real physical conditions,
including the initial distribution of TAF and fibronectin in the domain. Because of the
above modifications on the base model, our model predicts capillary network formation
based on real initial conditions, and the effect of matrix density is regulated by imposing
a function. This work also implements the MDE on the continuous model of angiogenesis.
Since the continuous model is the basis of the discrete model, the modifications of the
model make a better connection between the continuous and discrete models and change
the effect of the MDE from a local effect to a more extensive one. Our results do not
refute the results of Anderson and Chaplain, but, being based on real initial and boundary
conditions with some modifications, our results include the effect of matrix density and
capillary movement acceleration.
4.2 Continuous Mathematical Model of Angiogenesis
Once the ECs are activated by the VEGF, they start to migrate toward the VEGF gradi-
ents. Migration of ECs in the continuous model is modeled as the movement of aggregates
that represent the ECs. The aim of this model is to capture the EC motion in the ECM.
This model cannot give quantitative results and morphological details of EC motion; in-
stead, its importance is in its basic equations, which construct the discrete model.
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Three major mechanisms of motion have been considered in this model: random motil-
ity, chemotaxis and haptotaxis. Other mechanism for inhibition of angiogenesis such as
the effect of endostatin and andostatin could also be included in the model [107]. Each
of the motion terms can be described by the corresponding gradient of the motion stimuli
and suitable coefficients.
The first motion mechanism is random motility of the cell. For random motility, which
is modeled like the diffusion of mass due to the concentration gradient, the gradients of
EC density make a flux of ECs [4]
Jrandom = −Dn∇n (4.1)
where Dn is the random motility coefficient of EC, and n is the EC density.
The second motion mechanism is chemotaxis, which is related to the gradient of TAF
concentration. TAF is secreted by tumors in response to hypoxia. It diffuses through the
ECM and activates the ECs. In previous works [4, 63, 113], chemotactic effect has been
considered to decrease as ECs move toward the tumor. This effect has been introduced by
a function whose value is reversely proportional to the TAF gradient [4]. The chemotactic
function has been modified in this present work to capture more realistic behavior in the
growing capillaries. According to observations [31], the tip of a growing capillary should
accelerate as it approaches a tumor. There are also mathematical models that are in
agreement with the observation about acceleration of tip cells [57]. To implement this
behavior in the model, the effect of chemotaxis has been considered to increase during its
migration toward the tumor. The flux of ECs due to the TAF gradient is proportional to
the TAF gradient and EC density [4].
Jchemotaxis = τ(c)n∇c (4.2)
where c is TAF concentration, and τ(c) is the chemotactic function, which is considered
to increase linearly with increasing TAF concentration.
τ(c) = τ0(1 + κc) (4.3)
where τ0 is a chemotactic coefficient and κ is a positive constant.
The ECM contains various components, including interstitial tissue, collagen fibers and
fibronectin. Fibronectin is a macromolecule in the matrix and enhances the adhesion of
ECs to matrix components through integrin. Fibronectin is produced by both ECs and
matrix molecules such as fibroblast; however, the contribution of matrix molecules is much
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greater than that of ECs [57]. This phenomenon suggests an almost uniform distribution
of fibronectin in the domain. It should be noted that, in the case of non-uniformity in the
domain components, non-uniformity in the fibronectin production is expectable. In the
presence of a fibronectin gradient, an adhesive gradient is established in the ECM, which
directs the migration of ECs. During the migration, ECs search for stronger adhesion to
promote their adhesive bonds. Directional migration of ECs up an adhesive gradient in the
ECM is called haptotaxis, which is the third mechanism of EC migration in this model.
Haptotaxis flux is considered to have the following form [4]:
Jhaptotaxis = ψn∇f (4.4)
where f is the fibronectin concentration and ψ is the haptotactic coefficient.
In previous works [4, 96, 63, 15, 107], the effect of matrix density has not been observed.
Matrix density controls the migration speed of ECs and also their behavior. It has been
shown both numerically [6] and experimentally [90] that in low matrix densities, ECs
cannot establish a connection with matrix fibers, and so migration will not occur. In this
case, a kind of discontinuity is observed in the ECs, and they cannot form capillaries.
Moreover, at high matrix density, the dense medium of the ECM acts as a barrier and
reduces migration speed. Thus, the EC density flux due to the gradient of fibronectin and
TAF is multiplied by a function representing matrix density:
Jchem−hapto = Jchemotaxis + Jhaptotaxis = R(ρ)[τ(c)n∇c+ ψn∇f ] (4.5)
where R(ρ) is the function-regulating effect of matrix density in the model. The total flux
of ECs is given by the following equation:
Jn = Jrandom + Jchem−hapto (4.6)
These three motion mechanisms together form a conservation equation for cell den-




+∇.Jn = 0 (4.7)




= Dn∇2n−R(ρ)∇.[τ(c)n∇c+ ψn∇f ] (4.8)
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There are three dependent parameters in Equation 4.8, i.e., n, c and f, which should be
identified and updated during solution. EC density is updated from the above equation.
Two equations, for TAF and fibronectin concentration, are needed in the domain to update
the above expression for EC density in each time step. It can be assumed that TAF diffuses
through the ECM with a common diffusion equation.
∂c
∂t
= Dc∇2c− θc−B (4.9)
In Equation 4.9, Dc is the diffusion coefficient of TAF, θ represents its decay rate, and B is
the amount of TAF bound to the EC receptors. This equation gives the TAF concentration;
however, as the scale of time in this equation differs considerably from the scale of time in
the angiogenesis process, TAF concentration should be assumed to be independent of time
during solution, i.e., TAF diffuses much more rapidly in the ECM than in the angiogenesis
process, so its profile can be assumed to be steady. Despite the previous assumptions about
the profile of TAF in the domain [4], dimensional analysis of the TAF dynamics shows that
the profile of TAF in the domain is almost linear [5], so a linear profile has been assumed
for the TAF concentration distribution in the domain. This distribution has its maximum
value near the tumor and decreases to its minimum value near the parent vessel.
During migration of ECs in the ECM, there is some uptake and binding of TAF by




where λ is a positive constant showing the uptake of TAF by ECs.
Regarding the background fibronectin production of ECM molecules, which is much
more than the ECs production, a constant fibronectin profile is assumed in the domain.
The model for fibronectin production and uptake is given by the following formula [4]
∂f
∂t
= ωn− µnf (4.11)
where ω represents the production of fibronectin by ECs, and µ represents its uptake.
The complete system of equations, containing an equation for EC density and two
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The solution domain in this problem is ECM, which has the parent vessel on one side
and the tumor on the opposite side. The ECs start to migrate from the parent vessel to
the tumor in the ECM. The solution domain is considered to be a square area with the
dimensions [0, L]× [0, L], with the parent vessel on the left side and tumor on its right side.
The above set of equations is nondimensionalized to obtain a suitable form of the
governing equations in a [0, 1]× [0, 1] domain.
∂ń
∂t








where Z(ρ) is the nondimensionalized form of the matrix density function.













Figure 4.1: A schematic of the solution domain
The following nondimensionalized function is proposed for the effect of matrix density:




It should be mentioned that the non-dimensional values of n, c and f used in nondi-
mensional equations differ from their corresponding dimensional values.
A schematic of the solution domain is depicted in Figure 4.1. A periodic boundary
condition is assumed for the top and bottom sides of the solution domain, and no flux
boundary condition is assumed for the parent vessel and tumor.
ξ.{D∇n− Z(ρ)[χ0(1 + δc)n∇c+ φn∇f ]} = 0 (4.16)
where ξ is the normal outward unit vector.
An initial distribution should be considered for the EC density, the TAF, and the
fibronectin concentrations. For the EC density, an initial distribution has been considered
near the parent vessel with the profile in Equation 4.17 [4]





Figure 4.2: Initial endothelial cell density distribution in the domain
This profile, shown in Figure 4.2, provides an initial distribution of ECs near the parent
vessel. For TAF, as shown in Figure 4.3, a linear profile has been assumed in the ECM.
For fibronectin, as mentioned, a constant distribution has been assumed, as is shown in
Figure 4.4.
Table 4.1 shows the set of parameters used in the solution. The parameters with an
asterisk have been adapted based on the initial and boundary conditions for this model.




























Figure 4.3: Initial TAF concentration in the domain
Figure 4.4: Initial fibronectin concentration in the domain
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Table 4.1: Parameter values used in the simulation
Parameter description Symbol Value Reference
Random motility coefficient of EC in nondimensional-
ized equation
D 0.00035 [4]
Chemotactic coefficient in nondimensionalized equation χ0 0.16
∗ [4]
Coefficient in the chemotactic function δ 0.6 [97]
Haptotactic coefficient in nondimensionalized equation φ 0.34 [4]
Coefficient for uptake of TAF in nondimensionalized
equation
η 0.1 [4]
Coefficient for production of fibronectin in nondimen-
sionalized equation
β 0.01∗ [4]
Coefficient for uptake of fibronectin in nondimensional-
ized equation
γ 0.1 [4]
Matrix density reference value ρ0 0.35 [6]
Constant in the matrix density function σ 0.2
Constant in initial EC density distribution ε3 0.0025
∗ Parameters with an asterisk have been adapted for this model.


























































































h is the grid size, which is considered to be equal in both x and y directions, and q specifies
the time step.
The solution of the discretized equations is performed in an iterative process. Starting
with the initial values for EC density, TAF and fibronectin concentrations, a new value is
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obtained in each time step. This value is used as an updated value for the next time step,
and the solution continues until the specified time.
4.3 Implementation of MDE Model in the Continuous
Model of Angiogenesis
The above model was a development on the model presented by Anderson and Chaplain [4]
and used as the base of capillary network generation in some subsequent works [96, 63, 15,
107]. In this model, a general equation was considered for EC density, and two equations
were assumed for TAF and fibronectin concentration. Another important parameter, which
was not assumed in the previous continuous models, is the secretion of MDE by ECs and
which degrades the ECM locally to open the path for EC migration. Although in a more
recent work [63] another equation has been assumed for the MDE in the discrete model
and coupled with other equations, no attention has been paid to the continuous model.
Since the continuous model of angiogenesis is the basis of the discrete model, consideration
of its mathematical behavior is important in the quality of the capillary network generated
by the discrete model. Here, the MDE has been applied on the continuous model to see
its effect on the continuous model and also the effect of different model parameters on the
solution and results.
The governing set of equations for the continuous model of angiogenesis was presented
before in this chapter. This section introduces a new parameter, m, which is a concentration
of MDE.
MDE is representative of many proteases secreted by ECs. MDE is considered to be
a chemical agent produced by ECs, diffused through the ECM, and subject to a constant
decay rate. The governing equation for MDE concentration should involve appropriate
terms corresponding to its production, diffusion, and decay. An equation for the discrete
model presented by McDougall et al. has been changed here for the continuous model [63]:
∂m
∂t
= αn+ ε∇2m− νm (4.20)
where m is MDE concentration, α is the production rate of MDE, ν is the decay rate, and
ε is the diffusion coefficient of MDE.
It should be mentioned that the role of MDE is to degrade ECM locally and open a
corridor for EC transport. This effect is modeled by the action of MDE on the fibronectin.
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As MDE molecules act on the fibronectin, the fibronectin molecules are degraded, and a
gradient of fibronectin is established in the domain. In the case of MDE action, degradation
of fibronectin enhances the gradient in the fibronectin domain and acts as an additional
stimulus for haptotactic movement of the ECs.
In the continuous model of angiogenesis without MDE action, both a constant produc-
tion rate and a constant decay rate have been considered for fibronectin. These rates are
proportional to the EC density. To include the effect of MDE in the equations, a constant
production rate of β is assumed for fibronectin, a rate proportional to the EC density;
however, here, the degradation of fibronectin is assumed to be proportional to the MDE
concentration. To include this effect, the equation for fibronectin concentration is modified
to show its reduction in the presence of MDE [63, 97].
∂f
∂t
= βn− ζmf (4.21)
The final set of equations can now be written:
∂n
∂t









= αn+ ε∇2m− νm
(4.22)
The additional values used in this model are also obtained from the previous work
in this context [97] and shown in Table 4.2. The parameters with an asterisk have been
adapted based on the initial and boundary conditions for this model.
An initial profile should be considered for the MDE in the domain as shown in Figure
4.5. The profile used in this work is in accordance with the initial EC density distribution.
The discretization of the above equations with MDE is like that in the previous model
except for a slight difference in the equation for fibronectin concentration and also the
additional equation for MDE density. Using a central difference discretization scheme of
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Table 4.2: Additional parameter values in the model with MDE
Parameter description Symbol Value Reference
Production rate of MDE α 1∗ [97]
Diffusion coefficient of MDE ε 0.001∗ [97]
Decay rate of MDE ν 3 [97]
Decay rate of fibronectin due to MDE ζ 0.25∗ [97]
∗ Parameters with an asterisk have been adapted for this model.
Figure 4.5: Initial distribution of MDE in the domain
finite difference for the fibronectin concentration equation and also for additional equation
for MDE produces






















The above equations are solved by a method similar to the previously described iterative
method.
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4.4 Discrete Mathematical Model of Angiogenesis












In a discrete model of angiogenesis, the governing equations are the same except that the
values of P0, P1 , P2 , P3 and P4 are interpreted as the probability of an EC staying on
its current location, moving left, right, up or down, respectively. Each of the P0 to P4


















P2 is an estimation of the probability of an individual EC to move to the right, i.e.,
toward the tumor. The first term is the random motility contribution to this movement.
As can be seen in the equations for other Ps, this term is identical in all of them. The
coefficient D is representative of the diffusion that is a random movement mechanism
of ECs. The second term, which contains the local gradient of the TAF concentration,
is representative of the chemotaxis contribution, and the third term, which contains the
local gradient of fibronectin, states the haptotactic contribution to the final movement
probability.
To start the solution in a discrete model, we assume some individual ECs to be located
on the parent vessel (instead of the initial distribution of EC density in the continuous
model), and occupying certain grid points. The discrete model is based on the assumption
that the movement of the EC at the tip of the sprout coordinates the path along which
the capillary moves in the domain.
When an EC is in grid position (i, j ), and the probability-based movement algorithm
makes it move to right, it will occupy the grid point (i+1, j ) too. This kind of discrete
approach, coupled to our interpretation of the P values as some probabilities, makes this
method a promising tool for investigating and visualizing the movement of ECs toward the
tumor.
This approach has considerable complexity and also requires consideration of natural
behaviors of ECs like branching and anastomosis during their migration. These assump-
tions also add complexity to the coding procedure. The overall algorithm of a discrete
model may be stated as below:
1. Set initial parameters of the problem.
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Figure 4.6: The spectrum of probability distribution in discrete model of angiogenesis
2. Calculate the probability of movement of each individual EC.
3. Keep each EC in its location or move it right, left, up or down according to the value
of probabilities.
4. Check for anastomosis (tip to sprout or tip to tip).
5. If anastomosis is present, just one of the two ECs continues its movement.
6. Check for branching.
7. If branching is present, a new EC is added to the list of ECs for the next step.
8. Go to step 2.
The calculation of probability for each time step involves the solution of the equation
for governing five coefficients: P0, P1 , P2 , P3 and P4. As explained, these coefficients
are treated as the probability to remain stationary, move left, right, up and down, respec-
tively. These values are used in a spectrum of probability to determine the final movement
direction. This spectrum type interpretation of the probabilities is shown in Figure 4.6.
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To calculate the probability of movement, a random number between [0, 1] is generated.
Depending on its value, it falls in a range in the above spectrum, and EC movement is
determined according to the corresponding range.
As mentioned, these values are not probabilities in nature, but here are interpreted as
values related to movement probabilities. The summation of movement probabilities of
ECs in all directions in a time step should be equal to unity and none of the probability
values should be negative; however, in some time steps, the values of some Ps are negative,
and their summation is a value near unity. This issue occurs because, as stated, these
values are not probabilities but are interpreted values proportional to probabilities. It
should be mentioned that no specific problem arises from this issue.
The movement of an EC in any direction is possible; however, this study ignores back-
ward movement of ECs, i.e., setting P1 equal to zero. Since the probability values have
been normalized to the range of [0, 1], the absolute value of P1 is divided among other
movement probabilities.
The branching probability is determined according to a qualitative distribution that
gives the value of zero for the regions near the parent vessel (x < 0.25). As the distance
from the parent vessel increases, and capillaries get closer to the tumor, this value increases
to 0.2 for 0.25 < x < 0.45, 0.3 for 0.45 < x < 0.6, 0.4 for 0.6 < x < 0.68, and the value of
1 for x > 0.68 [4].
4.5 Implementation of MDE Model in the Discrete
Model of Angiogenesis
The system of equations for the case with MDE considerations in a continuous framework
was presented before. Similarly, in the discrete model, MDE is included in the model by













= αn+ ε∇2m− νm
(4.24)
The role of the additional equation is just to exhibit the role of MDE in the probability
values in the discretized form of the first equation.
The main difference between the MDE effect in the discrete model developed in this
study and that in the previous models [63, 97] is in local behavior. In the previous models,
a local production and diffusion of MDE is considered for ECs, i.e., a Boolean value has
been considered in the equations to show the presence of ECs at specific grid points. In
the model developed in this work, the production of MDE has not been modeled locally;
that is, production of MDE and degradation of fibronectin are not in specific grid points
determined by Boolean values, rather they take place in the region determined by the EC
aggregate. In fact, the physical effects of the continuous model are used directly in the
discrete model. This approach establishes a better relationship between the continuous
and discrete models, and the behavior of the discrete model can easily be predicted from
the continuous model.
4.6 Results
Results are presented in four distinct sections corresponding to the four modeling frame-
works for continuous and discrete models mentioned in this work. Each section presents
two sets of results. First, variation of the solution parameters is shown during the solution
for a matrix density of 0.15. Second, results of the solution in the final time step are shown
for matrix densities of 0.25, 0.35, 0.45 and 0.55. The overall trend of the solution param-
eters in all matrix densities is similar, so no solution details for matrix densities greater
than 0.15 are shown. It should be noted that T = 1 is equal to 1.5 days, T = 2 is equal to
3 days, and so on.
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Figure 4.7: Cross sections from initial distribution of EC density, fibronectin and TAF in
the domain
4.6.1 Continuous Model of Angiogenesis without MDE Consid-
eration
Results for the continuous model without MDE consideration are presented in this section.
The initial condition of the EC density, fibronectin and TAF has been introduced before
and is plotted in the cross section again in Figure 4.7. The variations of these profiles
during the iterations have been plotted in Figure 4.8 for the matrix density of 0.15. The
distance between parent vessel and tumor has been divided into 100 intervals.
Two main stimuli for EC movement and their corresponding gradients are seen clearly in
Figure 4.8. The curvature created in the fibronectin profile is due to production and decay
of this agent. As can be seen, a very low gradient of fibronectin reduces the haptotaxis
effect. The reduction in the apex of EC density during the solution is due to the propensity
of ECs to diffuse in the domain. The change in the distribution of the TAF is so small that
it cannot be observed at this scale. It should be noted that for fibronectin, the change is
so small that the limits of the diagram have been reduced to capture this change.
EC density distribution is shown for some other values of matrix densities in Figure
4.9. In these cases, evolution of the EC density profile during the solution is shown.
As observable in Figure 4.9, the function of matrix density is imposed on the model to
get the maximum migration speed in a matrix density of around 0.35.
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Figure 4.8: Cross sections from distribution of EC density, fibronectin and TAF in the
domain during the solution
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Figure 4.9: Distribution of EC density for matrix density values of 0.25, 0.35, 0.45 and
0.55 for the case without MDE consideration
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Figure 4.10: Cross sections from initial distribution of EC density, fibronectin and MDE
in the domain
4.6.2 Continuous Model of Angiogenesis with MDE Considera-
tion
Results for the continuous model with MDE consideration are presented in this section.
Since the TAF profile does not change notably during the solution, in the case of the
continuous model with MDE, the initial condition of the EC density, fibronectin and MDE
has been plotted in the cross section in Figure 4.10. The variations of these profiles during
the iterations have been plotted in Figure 4.11 for the matrix density of 0.15. The distance
between parent vessel and tumor has been divided into 100 intervals.
MDE action on fibronectin provides a gradient of fibronectin that makes the ECs move
faster. MDE is produced by ECs, so its distribution moves with the EC aggregate. In the
case of fibronectin degradation, haptotaxis has a notable role in the EC movement.
EC density distribution is shown for other values of matrix densities in Figure 4.12. In
these cases, evolution of the EC density profile during the solution is shown.
As observable in Figure 4.12, as in the case without MDE action in the model, the
function of matrix density is imposed on the model to get the maximum migration speed
in a matrix density of around 0.35.
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Figure 4.11: Cross sections from distribution of EC density, fibronectin and MDE in the
domain during the solution
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Figure 4.12: Distribution of EC density for matrix density values of 0.25, 0.35, 0.45 and
0.55 for the case with MDE consideration
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4.6.3 Discrete Model of Angiogenesis without MDE Considera-
tion
The continuous model of angiogenesis is the basis for the discrete model. The output in
the discrete model is a capillary network, based on the values of Ps, which are interpreted
as the probability of movement in different directions. In results presented for the discrete
model, the main focus is on the capillary network and probabilities. Other parameters such
as EC density distribution, fibronectin degradation and distribution, and TAF distribution
are similar to those in the counterpart continuous model. Results for the discrete model
without MDE are presented in this section. Initial conditions of EC density, fibronectin
and TAF are also similar to those in the continuous model. The capillary network and the
probabilities to move right (toward the tumor) and remain stationary for a matrix density
of 0.15 are shown in Figure 4.13.
As can be observed in Figure 4.13, the probability that ECs will remain stationary
decreases as capillaries move toward the tumor, and the probability of that moving right
(toward the tumor) increases. The bump-like shapes in the probabilities represent the effect
of fibronectin decay and production, which locally increases the probability of moving
to the right and decreases the probability of ECs remaining stationary. The movement
probabilities and generated capillary networks without MDE effect consideration for other
matrix densities are shown for T = 4 in Figure 4.14.
In the results presented in Figure 4.14, the probability of ECs remaining stationary
decreases as capillaries move toward the tumor, and the probability of them moving toward
the tumor increases. Increasing the matrix density up to 0.35 increases migration speed.
This can be concluded from the range of probabilities in each matrix density and the
resulting capillary network. After a matrix density of 0.35, increasing matrix density
decreases migration speed. The value of the probability of ECs moving back is set to zero,
and the values to move up and down are similar and change slightly during EC movement.
4.6.4 Discrete Model of Angiogenesis with MDE Consideration
Results for a discrete model with MDE are presented in this section. Initial conditions of
EC density, fibronectin, TAF, and MDE are similar to those in the continuous model with
MDE assumption. A capillary network and movement probabilities for a matrix density
of 0.15 are shown in Figure 4.15.
As can be seen in Figure 4.15, the probability that ECs will remain stationary decreases
as capillaries move toward the tumor, and the probability of that moving right (toward the
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Figure 4.13: Movement probabilities and resulting capillary network for matrix density of
0.15 without MDE effect
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Figure 4.14: Movement probabilities and resulting capillary network for matrix densities
of 0.25, 0.35, 0.45 and 0.55 in T=4
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Figure 4.15: Movement probabilities and resulting capillary network for matrix density of
0.15 with MDE effect
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tumor) increases. The bump-like shapes in the probabilities represent the degradation of
fibronectin and its production, which locally increases the probability to move right and
decreases the probability to remain stationary.
The movement probabilities and generated capillary networks with MDE effect consid-
eration for other matrix densities are shown in T = 4 in Figure 4.16.
In the results presented in Figure 4.16, the probability of ECs remaining stationary
decreases as capillaries move toward the tumor, and the probability of moving toward the
tumor increases. Increasing the matrix density up to 0.35 increases migration speed, which
can be concluded from the range of probabilities in each matrix density and the resulting
capillary network. The value of probability to move back is set to zero, and the values
to move up and down are similar and change slightly during EC movement. The values
of moving up and down can be estimated by subtracting the sum of probability values to
remain stationary and to the right from unity.
4.7 Discussion
In the continuous model of angiogenesis without consideration of MDE, the movement of
the EC aggregate is mainly due to random movement and chemotaxis. In this case, due
to very low gradients in the fibronectin profile, it is impossible to establish a movement
stimulus for the ECs. As can be seen in Figure 4.8, the curves in the fibronectin profiles
are produced as a result of fibronectin production and uptake, which do not provide strong
movement potential. The profile of TAF is not changed notably during solution, and an
almost constant TAF gradient is assumed throughout the domain. During the solution, the
EC distribution peak is lowered and decreases from the value of unity at the beginning of
the solution to a value of less than 0.4 in T = 3 (600 iterations). The EC density cannot be
changed during the solution since the total amount of ECs must be conserved. As shown
in Figure 4.8, the bell shape distribution of ECs in T = 2 and T = 3 is expanded at its
base, and this conserves the number of ECs, i.e., the total area under this curve remains
constant.
For the other values of matrix density in Figure 4.9, the results show that increasing
the matrix density from 0.15 to 0.25 makes ECs move faster. Faster movement is also
observed in a matrix density of 0.35; however, increasing the matrix density to 0.45 and
0.55 decreases migration speed. This issue occurs due to the function introduced before as
Z(ρ) to implement the effect of matrix density in migration speed.
The effect of MDE in the model is observed in the fibronectin profile in Figure 4.11.
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Figure 4.16: Movement probabilities and resulting capillary network for matrix densities
of 0.25, 0.35, 0.45 and 0.55 in T=4 with consideration of MDE
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MDE degrades the fibronectin, creating a gradient in the fibronectin profile. This gradient
enhances the haptotactic movement potential and accelerates the ECs’ movement. Since
the fibronectin gradient is stronger as the ECs aggregate downwards, the EC density is
squeezed, creating higher peaks during the solution.
EC movement in the other matrix densities shown in Figure 4.12 is like the case without
MDE consideration but with a slight change in migration speed. ECs move faster with
MDE consideration than without it because the established gradient in the fibronectin
profile gives the ECs a higher migration speed. The highest migration speed is observed
in matrix densities of around 0.35, a finding similar to the case without MDE. In all cases,
assumption of MDE provides a higher peak in EC distribution, which, as mentioned before,
is due to the fibronectin gradient.
In the discrete model of angiogenesis, the values of Ps are interpreted as the probability
of movement. The portion of each P value in the total movement probability determines
the capillary network configuration. Since the continuous model is the basis for the discrete
model, without MDE, haptotaxis is not expected to exhibit a notable effect. The formation
of a capillary network for a matrix density of 0.15 is shown in Figure 4.13. The probability
of ECs remaining stationary or moving right is also shown each time.
One of the main advantages of the current model is its physical probability distribution,
seen in Figure 4.13. In the previous discrete models, the probability to move toward a
tumor is decreased as a consequence of unrealistic assumptions about fibronectin and TAF
distribution.
In contrast, this work has modified the initial distribution of fibronectin and TAF in the
domain according to physiological observations about fibronectin and mathematical anal-
ysis of TAF distribution, respectively. This study also assumes that the role of chemotaxis
increases linearly as capillaries move toward the tumor. These assumptions have helped to
establish a physical distribution of probabilities in the domain. As can be seen in Figure
4.13, when ECs move toward the tumor, the probability of their moving right increases,
and the probability of their remaining stationary decreases. There is a small bump in the
probability distribution profile that moves in the direction of the tumor. This bump is
almost coincident with the tip cells of the capillary network. The bump shows the effect of
fibronectin degradation in the domain. As discussed, the effect of fibronectin degradation
in the continuous model was slight. Here, a small increase in the probability to move right
is produced due to this effect. In Figure 4.13, in T = 4, the ECs are almost half way to the
tumor. The capillaries were not allowed to continue their motion to provide a means of
comparing migration speed, so this study presents the resulting capillary network in T = 4
for matrix densities of 0.25, 0.35, 0.45 and 0.55 in Figure 4.14.
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Certain points should be noted about Figure 4.14. First, increasing the matrix density
to 0.25 increases the range of probabilities, thereby providing faster migration of ECs in
the domain. At the same time, the probability of remaining stationary decreases, which is
in agreement with the increase probability of moving right. At a matrix density of 0.35,
the probability to move right increases further and is at maximum. At matrix densities of
0.45 and 0.55, the probability of moving right lessens. This issue corresponds to migration
speed, and, as seen in Figure 4.14, the maximum range of probability of movement right
is at a matrix density of 0.35. The capillary network also propagates more at this matrix
density. As discussed, we expected that at low matrix densities, capillaries would not
establish good connections with matrix elements. Moreover, by increasing matrix density,
it was expected that the high density of the matrix would inhibit angiogenesis. This issue
has been implemented by the function Z(ρ) in the main equation. This function regulates
the effect of haptotaxis and chemotaxis as a function of matrix density. The second point
worth noting is the small bump still seen in these results in Figure 4.14. It is again the
effect of fibronectin decay and moves with ECs in the solution domain.
The most interesting part of this study is the case of the discrete model when MDE is
considered. The growing capillaries for the matrix density of 0.15 are shown in Figure 4.15
four times. This figure again shows the increasing trend of probability to move right and
the decreasing trend of probability to remain stationary. In comparison to the probability
distribution for the case without MDE in a matrix density of 0.15, considering of MDE
does not change the overall range of probabilities; however, MDE consideration affects the
probability distributions. Two bumps are seen in the probability distribution profiles: the
bump near the parent vessel, due to the initial concentration of MDE, and the bump due
to fibronectin degradation, caused by the movement of ECs in the domain. It should be
noted that in this case, the bump is bigger than in the case without MDE, meaning that
fibronectin degradation has a more pronounced effect in this case. Moreover, compared to
the similar case without MDE, the more ECs developed and migrated faster. The higher
migration speed in this case is the result of the two bumps seen in Figure 4.15. The
bumps locally increase the probability of tip cells moving right, and this will lead to higher
migration speed.
For other values of matrix density shown in Figure 4.16, we have made observations
similar to those in the case without MDE. The two bumps help the probabilities to push
the ECs more toward the tumor. Also the maximum migration speed is observed in the
matrix density of 0.35 and is imposed in the equations by the function Z(ρ).
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4.8 Conclusion
This chapter presents modifications of some features of the previously presented continuous
and discrete models of angiogenesis. These modifications are on the initial distribution of
fibronectin and TAF in the domain and also in the interpretation of the effect of MDE in
the continuous and discrete model. MDE was implemented on the continuous model for the
first time in this study. Additionally a function for matrix density effect allowed the effect
to be implemented in the equations and solution. One of the main advantages of this work
is the realistic probability distribution in the domain. The capillaries should accelerate as
they move toward the tumor, meaning that probability to move right should increase as the
capillaries move toward the tumor. Changing the function of the chemotactic coefficient
and also real initial conditions leads to realistic probability distribution in the domain,
which shows an increased probability to move right as capillaries migrate toward the tumor.
Fibronectin degradation is clearly shown to establish haptotactic movement, and in the
absence of MDE, the expected haptotactic movement decreases.
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Chapter 5
Capillary Network Flow in Solid
Tumor Microvasculature
5.1 Introduction
Although heart and blood vessel diseases were the main causes of death for many years,
more than 12 million new cancer diagnoses were reported in 2011, making it the new
leading cause of death. More than 85% of cancers involve solid tumors; therefore, better
understanding of tumor formation is very important in cancer therapy [43]. In terms of
modeling, solid tumor growth can be characterized in two different phases: the avascular
and vascular. Relying only on diffusion from nearby vessels to supply oxygen and nutrients,
the first phase usually continues until a tumor reaches the diameter of a few millimeters
[30]. To grow further, a solid tumor needs its own blood supply, in the form of, and supplied
by, a capillary network.
The main barrier to successful drug delivery to solid tumors is their abnormal and
complicated vasculature [102]. The high interstitial pressure and low intravascular pressure
near the tumor affect drug transport, causing slow flow through the tissue and low filtration
of drugs from vessels. Solid tumor simulation results are used to predict how therapeutic
drugs are transported to tumor cells by blood flow through capillaries and tissues and to
identify better methods for delivering targeted anticancer therapies [74, 42].
Solid tumor growth modeling involves many complicated processes on a wide range of
spatial and temporal scales. This multi-scale nature of tumor formation makes the govern-
ing equations involved in the mathematical modeling highly complex to solve. Multi-scale
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modeling involves: the convection and diffusion of fluid flow in normal and tumor tissues at
the largest scale, blood flow distribution through a network generated by tumor-induced
angiogenesis at the middle scale and blood flow convection in capillary by considering
non-continuous behavior of blood and adaption of capillary diameter at the smallest scale
(Figure 5.1).
Modeling of diffusion and convection of flow in solid tumor tissue while considering
the domain to be a porous medium with a uniform source and sink of blood flow is often
undertaken. Jain et al. [44, 8, 45] used a model of a spherical tumor that had continuously
distributed vasculature in the presence of the lymphatic system. The main assumption used
to calculate pressure distribution in their model is that the net flow into the interstitial
space from the vasculature is balanced by the efflux to the lymphatic system through
Starling law.
In the modeling of Netti et al. [69], tumor vasculature was treated as an equivalent
permeable vessel embedded in a uniform-pressure medium. Simulations were used to ex-
amine the effects of vessel leakiness and compliance, and interstitial fluid pressure. Soltani
et al. [92], using a numerical element-based finite volume method for modeling a contin-
uum equation in the porous media of spherical tumors, developed a mathematical model
of interstitial fluid flow that introduced two new parameters: the critical tumor radius and
critical necrotic radius. They have also applied their numerical model to different shapes
of tumors to study the effects of tumor shape and size in drug delivery [93]. None of these
works consider the effects of a tumor-induced network generated by tumor angiogenesis on
fluid flow in normal and tumor tissues.
McDougall et al. [64] and Stephanou et al. [96] have examined flow modeling in a
tumor-induced capillary network. They use continuous and discrete mathematical models
of angiogenesis, described by Anderson and Chaplain [4], for generating a capillary network.
The continuous model uses differential equations and is based on the mass conservation
equation and chemical kinetics [4]. The discrete method of angiogenesis modeling uses
the same kind of equations as the continuous model but with different interpretation of
the probability quantities [4]. This method is able to model the growth and motility of
endothelial cells. The advantages of this method make it suitable for use in more detailed
models that consider flow and its effects on angiogenesis [64, 96]. Anderson and coworkers
[64, 96] performed a Newtonian fluid flow simulation through 2D and 3D rigid capillary
networks in order to investigate chemotherapy treatment efficiency. Zhao et al. [114]
presented a numerical model that combines intravascular, transvascular, and interstitial
fluid movements in 2D capillary networks originating from tumor-induced angiogenesis.
They later extended their work to 3D [108]. None of the above works consider the non-
Newtonian rheological properties of blood in capillaries and remodeling of microvessels in
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tumor-induced networks.
The non-continuous behavior of blood in capillaries and vascular adaptation has also
been incorporated into models including capillary networks [71, 63, 97, 2, 3]. The non-
continuous behavior of blood includes variation of blood viscosity, with tube diameter
and hematocrit (the fraction of the total volume of blood occupied by red blood cells),
and an unequal fraction of hematocrit between the branches of capillary bifurcation. The
capillaries adapt their diameter based on signals received from hemodynamic stimuli such
as wall shear stress, pressure, and metabolic stimuli. Alarcon and co-workers developed
a multi-scale model of vascular tumor growth linking vascular adaptation, blood flow,
oxygen, and growth factor transport at the tissue scale to the subcellular and cellular
dynamics of normal and cancerous cells [2, 3]. In their most recent work [71] the topology
of the vasculature modeled by 2D regular hexagonal networks is changed from a static
to a dynamic network in which new vessels and connections between existing vessels are
considered.
Stephanou et al. [97] modeled an adaptable vasculature associated with tumor-induced
angiogenesis and considered phase separation of blood flow in bifurcation and non-Newtonian
behavior of blood. They investigated the effects of this remodeling on the supply of drugs
to tumor cells. McDougall et al. [63] introduced several improvements in a model presented
in [97], by examining the flow of a non-Newtonian fluid in a dynamic adaptive network. A
mathematical model is presented that simultaneously combines vessel growth with blood
flow through a microvessel. In the modeling of Alarcon and co-workers and McDougall and
coworkers, only intravascular blood flow is considered, and the independency of transvas-
cular flow from the interstitial flow surrounding the microvessels instead of coupling is
supposed. No transvascular flow is taken into account.
Wu et al. [109] developed a mathematical model of tumor microcirculation, which
couples microvasculature and interstitial space perfusion, and combines the intravascular
and interstitial flow permitted by vascular permeability. In their work, only the vessels
located in the tumor region are considered to adapt their diameter based on the compliance
method presented by Netti et al. [69]. They used a model of angiogenesis presented in a
previous paper [114], considering two distinct parent vessels to be the arteriole and venule.
However, as known, the structure of the tumor-induced capillary network is extremely
disorganized, and differentiating the venules from the arterioles is often problematic [74];
therefore, assuming separate arteriole and venule vessels does not seem realistic. In the
adaptation method used by Wu et al. [109], the effects of hemodynamic and metabolic
stimuli are not considered, and their compliance method is implemented only in vessels in
tumor tissue. Vessels in normal tissue are assumed to have a constant diameter.
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In spite of valuable work in the simulation of fluid flow in normal and tumor tissues,
previous studies have not considered a model that explores the effect of capillary network
adaptation by hemodynamic and metabolic stimuli on interstitial pressure. To address this
omission, this thesis introduces a mathematical model that simultaneously couples inter-
stitial fluid flow with convection non-continuous blood flow through vessels by considering
a remodeling network based on hemodynamic and metabolic stimuli.
This thesis formulates a non-continuous blood flow model through a capillary network
induced by a tumor combined with interstitial flow in normal and tumor tissues, taking
into account the extravasation flux of fluid across the vasculature. First, the governing
equations of sprouting angiogenesis are implemented to specify a capillary network in the
interstitium domain. A discrete method first presented by Anderson and Chaplain [4] is
used to create the vascular network in both normal and tumor tissues. Then, governing
equations are introduced for blood flow through the capillary network and fluid flow in
the interstitium. Finally, the effects of the capillary network on interstitial fluid flow are
studied, considering three approaches for simulation of blood flow in the network. First, the
governing equation for the interstitium is solved without considering a capillary network,
as in [45, 92, 93]. Second, similar to the approach used in [64, 96, 114], the tumor-induced
network is presumed to have rigid capillaries, and blood flow is calculated in the network
by mass conservation at each junction. In the third approach, the capillaries are assumed
to adapt their diameters in response to signals received from metabolic and hemodynamic
stimuli. The remodeling method presented by Pries et al. [78] is used. For this reason,
phase separation, based on the method presented by Fung, is involved in the third approach
[32] and also the non-Newtonian behavior of blood, based on the formula presented by Pries
et al. [77], is implemented. Results show that fluid flow modeling in normal and tumor
tissues with a rigid vascular network can predict higher pressure than the method studied
in the previous research on interstitial flow [92]. The approach considering adaptable
capillaries, which is more accurate, shows even higher pressure than the second approach
does.
5.2 Mathematical Model of Angiogenesis
The mathematical model used for generation of the network has been described in Chapter
4. A schematic of the solution domain in this chapter is shown in Figure 5.2
To generate the networks, two initial conditions for the number of ECs in a parent vessel
are considered: 5 ECs and 10 ECs. Results of capillary network formation are shown in
Figures 5.3 and 5.4. These networks are used for further studies in section 5.3.
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Figure 5.1: Schematic representing different scales in a solid tumor
Figure 5.2: Schematic of the solution domain
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Figure 5.3: Results of discrete model. Five initial sprouts move toward the tumor on the
right side of the domain
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Figure 5.4: Results of discrete model. Ten initial sprouts move toward the tumor on the
right side of the domain
88
5.3 Flow Simulation in Capillary Networks
Calculation of fluid flow in networks is used in many fields of physics, such as the water
and petroleum industries. The analysis of blood flow in microvascular networks is generally
the same as the analysis of other networks, but with a few significant differences. These
differences are due to the permeability of vessels, changeable diameters of vessels, non-
continuous behavior of blood in micro-scale vessels, and the porous nature of the medium
surrounding vessels. In this section, the governing equations for a network and porous
media are presented. Then the models used for the non-continuous behavior of blood and
vessel adaptation are introduced.
To study incompressible flow through a network of vessels, the flow rate in each vessel
is calculated by applying mass (or volumetric flow rate) conservation at each junction of
the network. The equation representing the volumetric flow rate for an interconnecting
point like c (Figure 5.5) in the network can be written as
N∑
k=1
Qkcβk = 0 (5.1)
where the index k refers to adjacent nodes, and N is the number of adjacent nodes. In
2D simulation for a fully connected network, N is 4, and βk is a positive integer ’1’ or ’0’,
which describes whether nodes c and k are connected (βk = 1) or not connected (βk = 0).
Qkc is the net flow rate for each capillary and includes the flow through the capillary




where QkB,c is blood flow through each capillary and Q
k
t,c is the extravasation flux of fluid
across the vascular or transvascular flow.
Blood flow in capillary tubes has a low Reynolds number, much less than 1. For such
a low Reynolds number, Poiseuille’s law can be applied. Poiseuille’s experiment shows the
relationship between the flow rate QkB,c and the driving pressure ∆P in a tube of diameter







where ∆P is calculated by P cB − P kB.
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Figure 5.5: Schematic representation of blood flux at each vascular node
The transvascular flow rate is calculated by Starling’s law, which represents the role
of hydrostatic and oncotic pressures in the movement of fluid across capillary membranes.
Starling’s law [32, 84] is calculated by
Qkt,c = πDLLp[P̄B − P̄i − σs(πB − πi)] (5.4)
where











πB is the osmotic pressure of the plasma
πi is the osmotic pressure of the interstitial fluid
Lp is the hydraulic conductivity of the microvascular wall
σs is the average osmotic reflection coefficient for the plasma proteins.
Calculation of transvascular flow rate depends on the intravascular pressure in vessels
and interstitial pressure in normal and tumor tissues. The intravascular pressure is found
by solving the mass conservation equation in the network by applying Poiseuille’s equation
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Figure 5.6: Schematic representation of blood flux through microvessel or transformation
from microvessel and related parameters
for flow in vessels as mentioned. The interstitial pressure for the peripheral tissue of a
vascular network is found by solving the governing equation for fluid flow through a porous
medium. In fact, Equation 5.4 couples blood flow in the network and fluid transport in
the tissue around the network.
The tissues, such as normal and tumor, have properties like those of a porous medium.
One of the earliest formulations for flow transport in porous media is Darcy’s law. Darcy’s
empirical observations show that the fluid velocity in porous media is proportional to the
pressure gradient; therefore, fluid transport in the porous media can be described by the
following equation [32, 11, 25]:
Vi = −k∇Pi (5.5)
where
Pi is the interstitial pressure as defined before
k is the hydraulic conductivity of the interstitium
Vi is the interstitial fluid velocity.
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The mass balance equation for a steady state incompressible fluid shows that the di-
vergence of the velocity is zero, or mathematically,
∇.Vi = 0 (5.6)
This equation is acceptable for porous media when there is no fluid source or sink
in the medium, but biological tissues have sources and sinks. For instance, between the
interstitial space and the blood or lymph vessels, fluid is exchanged; therefore, the steady
state incompressible form of the continuity equation must be modified as in [92].
∇.Vi = φB − φL (5.7)
where
φB is the rate of fluid flow per unit volume from blood vessels into the interstitial space,
and
φL is the rate of fluid flow per unit volume from the interstitial space into lymph vessels.
It should be noted that Equation 5.7 in its general form is applicable to any kind of
biological tissue, whether normal or cancerous. In this simulation, the value for lymph
vessels is neglected. The blood vessel terms (or fluid source terms) can be evaluated




[P̄B − P̄i − σs(πB − πi)] (5.8)
where S
V
is the surface area per unit volume of tissue for transport in the interstitium.
Other terms in Equation 5.8 were introduced previously in this section.
The mass conservation equation is obtained for normal and tumor tissues with a capil-
lary network by adding a source term for mass flow to the right-hand side of the continuity
equation wherever there is a capillary; otherwise, the right-hand side of the continuity





(P̄B − P̄i − σs(πB − πi)), for existence of blood source;
0, otherwise.
(5.9)






(P̄B − P̄i − σs(πB − πi)), for existence of blood source;
0, otherwise.
(5.10)





(P̄B − P̄i − σs(πB − πi)), for existence of blood source;
0, otherwise.
(5.11)
Applying the appropriate boundary conditions and also using all the constants men-
tioned earlier, the governing equation, Equation 5.11, can be used to calculate interstitial
fluid pressure in both normal and tumor tissues. As shown in Figure 5.7, a no-flux bound-
ary condition is considered for the right-hand side of the domain and upper and lower
limits of the domain, i.e.,
∇Pi = 0 (5.12)
For the left-hand side of the domain near the parent vessel, the constant value of
pressure is considered.
Equation 5.1, by considering Equations 5.2 to 5.4 and Equation 5.11, should be solved
simultaneously to find the intravascular, PB, and interstitial, Pi, pressures. The solution
can be obtained numerically to find both PB and Pi, and other related parameters such
as velocity and flow rate. The iterative numerical method, Gauss-Seidel [76], is applied
to solve the system of equations for intravascular pressure. A finite difference method is
applied to discretize Equation 5.11. The discretized form of the governing equations, in
their general form, is then linearized and solved explicitly by an iterative procedure. This
iterative method can be called semi-implicit, as during the solution, the most updated
values of pressures are used. The algorithm for the procedure and discretized form of the
equations is described in Section 5.4.
5.3.1 Blood Viscosity in Capillaries
As mentioned, Poiseuille’s law can be used for Newtonian flow, but blood has significant
non-Newtonian properties at low Reynolds numbers. Blood viscosity in capillaries depends
on the vessel diameter and hematocrit. To take advantage of Poiseuille’s law’s simplicity
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Figure 5.7: A schematic of calculated domain for fluid flow simulation
and use it to show the behavior of blood, it is helpful to define the apparent or effective







Pries et al. [77, 81] used data obtained from the results of 18 studies of human blood
and combined the data with a parametric description of apparent blood viscosity relative
to the viscosity of plasma to define apparent viscosity. They introduced this parameter as
the relative apparent viscosity. A description of relative apparent viscosity as a function
of the tube diameter and hematocrit is as follows [77]:
µrel = [1 + (µ45 − 1)
(1−HD)C








µ45, the relative apparent blood viscosity for a fixed hematocrit of 0.45, is given by
µ45 = 6e
−0.085 + 3.2− 2.44e−0.06D0.645 (5.15)
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Figure 5.8: Apparent viscosity profiles as a function of vessel radius for different hematocrit
values
where D is the vessel diameter (in µm), and C describes the shape of viscosity dependency
on the hematocrit, defined as







µapp = µplasma.µrel (5.17)
The apparent viscosity corresponding to Equation 5.14 in a range of typical capillary
radii for different hematocrit values and considering µplasma = 1.2 is plotted in Figure
5.8. It can be seen that the apparent blood viscosity generally increases with a decrease in
capillary diameters (Fahraeus-Lindquist effect), although the precise relationship is actually
hematocrit-dependent. The two parameters, hematocrit and vessel diameter, affecting
blood viscosity are dependent on blood flow characteristics such as velocity, wall shear
stress, pressure in vessels. These dependencies are described in the next sections.
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Figure 5.9: Schematic of different patterns of blood flow in networks: a) Blood flow from
one (two) node(s) into one (two) node(s). b) Blood flow from three nodes into one node.
c) Blood flow from one node into three nodes.
5.3.2 Phase Separation at Capillary Bifurcations
Since µrel depends on H, the hematocrit distribution has a significant role in simulating the
hemodynamic characteristic of the vessel network. In general, H distribution at a vessel
bifurcation depends on the flow velocity in each branch. The total red blood cell fraction
in the feeding vessel of a bifurcation that goes into one of the daughter branches is not
essentially the same as the fractional blood flow going into that branch. It has been shown
that all the hematocrit goes into the branch with the faster velocity at bifurcations if the
velocity at that branch goes beyond a certain limit. Extending Fung’s conclusions [32]
results in the distribution rules of H, as follows (see Figure 5.9 for definitions, assuming
UB2 ≥ UB3 ≥ UB4) [2]:
a)Blood flow from one (two) node(s) into one (two) node(s) (Figure 5.9a)















b)Blood flow from three nodes into one node (Figure 5.9b)
Hi = max(H1, H2, H3) Hi = H4 (5.19)
c)Blood flow from one node into three nodes (Figure 5.9c)































where Hi denotes H at node i, ζ is a phenomenological parameter that accounts for the
strength of the non-symmetry of the hematocrit distribution at bifurcations [2], and Ucr is
the critical ratio of the velocities of the branches, above which, the total hematocrit goes
to the faster branch [2]. Here, the hematocrit in the parent vessels and their joint nodes
with the connected induced network is assumed to be a constant 0.45.
5.3.3 Vessel Diameter Adaptation
Capillaries are able to continuously adapt their diameter in response to the functional
requirements of the tissues that capillaries supply [78, 82]. Each vessel responds locally
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to physical and biochemical stimuli. In fact, wall shear stress and intravascular pressure
created by blood flow lead to remodeling of the vascular diameter. The biochemical stimuli
such as the metabolic are also able to remodel the capillary network generally. For each
vessel in the network, the change of its diameter (∆D) for a time step (∆t) is assumed to
be proportional to the stimulus term, its initial diameter, and the time step:
∆D = Stot.D.∆t (5.21)
Stot includes the influences of the wall shear stress (Swss), the intravascular pressure
(Sp), and a metabolic mechanism depending on the blood hematocrit (Sm). Each stimulus
is next briefly discussed.
5.3.4 Wall Shear Stress
Experimental observations show that to maintain a specific level of wall shear stress, the
vessels adapt their diameter. Murray [65] showed that when the volumetric blood flow rate
in each vessel is proportional to the cube of the vessel diameter, the energy consumption
for pumping the blood to the circulatory system is minimal. The wall shear stress in a





Based on Equation 5.22, to satisfy Murray’s law, wall shear stress needs to be approxi-
mately constant in vessels. Therefore, when each vessel senses wall shear stress, it adjusts
its diameter to achieve a uniform level of stress. Experimental observation [80] shows that
vessel diameter increases when wall shear stress increases. This stimulus is described by
the following logarithmic law:
Swss = log10(τw + τref ) (5.23)
where τw is the actual wall shear stress in a vessel segment calculated by Equation 5.22,
and τref is a small constant included to avoid singular behavior at low wall shear stress
rates.
Considering only wall shear stress for vessel adaptation tends to give unstable remodel-
ing. The instability causes the diameter of one vessel in a parallel connection to approach
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zero and the other one to carry the entire flow. Another problem of considering only wall
shear stress is that the vessel diameters must be equal on both the arterial and venous sides.
5.3.5 Intravascular Pressure
Shear stress values differ significantly between arterial and venous vessels. The values in
the arterial system are always greater than those in a venous one [80]. Studying structural
adaptation, Pries et al., suggested a preset relationship between local intravascular pressure
and wall shear stress [79]. They showed that increasing intravascular pressure decreases
vessel diameter. To consider the corresponding stimulus of intravascular pressure, they
suggested a negative sensitivity represented by the following equation:
SP = log10 τe(PB) (5.24)
in which τe(PB) is the wall shear stress resulting from the blood pressure ,PB, based on the
experimental data on rat mesenteries [79]. As shown in Figure 5.10, this wall shear stress
increases, in a sigmoidal shape, as pressure increases.







In this equation, pressure and stress are obtained in mmHg and Pa, respectively. As
shown in Figure 5.10, for pressure less than 10mmHg, Equation 5.25 is not applicable.
Instead, the value of 1.4Pa is considered.
5.3.6 Metabolic Hematocrit-related Stimulus
The metabolic requirement of tissue can affect and control vascular diameter. A drop in
oxygen supply or other metabolic material stimulates the vessel to increase its diameter
to enhance perfusion. Pries et al. [78, 82] suggested adding a stimulus dependency to
the volume flux of red blood cells passing through a vessel (represented by QBH), thus,
increasing this volume flux decreases the stimulus effect. This stimulus is once again
described by a logarithmic law, given by
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Figure 5.10: Shear stress induced by intravascular pressure in a range of pressure in a circu-
latory system. Equation is derived by Pries et al. [79] using curve fitting from experimental








where Qref is the largest value of QB in the network. In this simulation, the flow rate of
parent vessels corresponds to Qref .
5.3.7 Vascular Adaptation
The total signal for diameter adaptation is represented in the model by the following
equation, which remodels the structure of the capillary network.
Stot = Swss − kpSp + kmSm − ks (5.27)
Here, the parameter kp is introduced to indicate the adaptive response sensitivity of
vessel diameters to changes in intravascular pressure [78]. km is the sensitivity of the
adaptive response of the vessel diameter to changes in metabolic state [82].
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The vessel has a tendency to reduce in size in the absence of positive growth stimuli.
The shrinking tendency, ks, is applied to show this tendency [82]. Finally, the model for
vessel adaptation is given by the following equation:
∆D =
[









Intravascular pressure is numerically calculated at each node by integrating Equations 5.1,



























where q is the number of iterations. This procedure leads to a set of linear equations
for the nodal pressures. These equations can be solved numerically using the Successive
Over-Relaxation (SOR) algorithm. Once nodal pressures are known, Equation 5.3 can be
used to calculate the flow in each capillary element in turn.
The interstitial pressure is found by solving Equation 5.11. The iterative numerical



















where q again is the number of iterations, and Ac,k is 1 or 0, describing the existence of a
blood source. To solve this equation, the SOR algorithm is used.
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5.4.1 Algorithm for Calculating Fluid Flow in Capillaries with
Remodeling
The fluid flow calculation in capillary vessels includes a set of non-linear equations. For
this reason, an iterative procedure is applied to solve the fluid flow and remodeling in a
capillary network. The procedure is as follows:






2. Calculating PNB , P
N
i iteratively based on Equations 5.29 and 5.30 as described,
3. Calculating the total adaptive stimuli using Equations 5.23, 5.24 and 5.26,
4. Updating vessel diameter D using Equation 5.28,
5. Calculating QB by Equation 5.3,




7. Finding H by a procedure described in Section Phase Separation at Capillary Bifur-
cations,
8. Updating the apparent viscosity by Equation 5.14,
9. Calculating the relative error for PB ,Pi and D by max(
XN−X0
X0
), where X can be
each of PB ,Pi and D,
10. Checking the maximum relative error of PB, Pi and D with a criteria solution which
is considered to be 1e− 6,
11. If the error is greater than the solution threshold, the iterative procedure returns to
step 2, and the new solutions of PB, Pi, µapp, H and D are substituted for the previous
values. Otherwise, the iteration procedure is considered to be finished.
5.5 Model Parametrization and Simulation Details
5.5.1 Initial Conditions
The 2D domain (shown in Figure 5.7) considered for the computational simulation studies
is a square of length Lx = Ly = 2mm, and the parent vessel from which the vascular
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network grows is located at the left edge of the domain. The tumor is located along the
right edge of the domain boundary. The equations for tumor-induced capillary growth are
solved numerically on a 100 × 100(x, y) square grid. P 0i is initialized to be zero, and P 0B
is considered to be 1330Pa, based on boundary condition [8].
5.5.2 Intravascular Flow Model Parameters
In order to simulate the fluid flow in capillaries, several important physical and biological
parameters must first be estimated.
5.5.3 Vessel Properties
The initial diameter of each capillary segment is assumed to be 12µm, and for the parent
vessel it is 28µm, a value that stays constant during the remodeling procedure. During the
remodeling process, allowable diameter changes are in the range of 4µm to 24µm [20].
5.5.4 Adaptation Parameters and Phase Separation
Parameters used for the adaptation model and phase separation presented in Equations
5.18 to 5.20 and 5.28 are listed in Table 5.1.
Table 5.1: Parameter values used in the adaptation
Parameter Value Reference




















in which Qref is the flow rate in the parent vessel, calculated by Equation 5.3 assuming
D = 28µm, L = 2mm and ∆P = 1950Pa (15mmHg) (the pressure drop across the par-
ent vessel), and µapp = 0.0031[Pa.s] calculated by Equation 5.14. The plasma viscosity,
µplasma, is assumed to be 1.2× 10−3 Pa.s. The discharge hematocrit H = 0.45 is assumed
to stay constant in the parent vessel [78]. The intravascular pressure, PB, is an important
factor in the vascular remodeling process. In this simulation, inlet and outlet pressures
are chosen in the hope of guaranteeing that the average intravascular pressure is about
2660Pa (20mmHg), based on the physiological values reported in the literature [97]. Tak-
ing into account the physiological condition at microvascular scale results in considering
3325Pa (25mmHg) for the inlet and 1330Pa (10mmHg) for outlet pressures.
5.5.5 Interstitial Flow Model Parameters
The material properties for tumor and normal tissue used for interstitial flow calculation
are taken from the simulation study in Chapter 2 and are shown in Table 5.2.
Table 5.2: Material properties used in numerical simulations, as taken from [44]
Parameter Normal Tissue Tumor Tissue
Lp[cm/mmHgs] 0.36× 10−7 2.80× 10−7
K[cm2/mmHgs] 8.53× 10−9 4.13× 10−8





Three approaches are used for calculating interstitial pressure in a cancerous tissue. First,
the results of the initial approach are presented by solving the governing equations for
normal and tumor tissues without a network, as in work done in Soltani et al. [93, 92].
Then the results of the second approach are obtained by simulating fluid flow in a net-
work induced by tumor angiogenesis with constant values for blood rheology and vessel
diameters. Finally, results obtained using the proposed realistic approach, in which the
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Figure 5.11: 3D graph of interstitial pressure in the computational domain for both normal
and tumor tissues in which uniform distribution and constant values for intravascular
pressure are assumed.
non-continuous behavior of blood and adaptability of capillary diameters are assumed, are
investigated.
As mentioned, to show how a capillary network affects the fluid flow in normal and
tumor tissues, the tumor’s interstitial fluid flow is simulated without considering such a
network. For this simulation, it is supposed that intravascular pressure, PB, has uniform
distribution in the domain and is constant throughout the simulation. A 3D plot of this
interstitial pressure distribution is shown in Figure 5.11. Figure 5.12 shows a 2D contour
of interstitial pressure.
Now, results of fluid flow in normal and tumor tissues are presented by considering
the capillary network induced by the tumor. The data on vessels’ connection of networks
shown in Figures 5.3 and 5.4 are used for the simulation of blood flow. Before solving the
fluid flow, the network must be pruned. As the network has some segments that do not
make a loop, these are removed. That is, each segment should have at least two neighbors,
so if a segment has less than two (0 or 1), it is killed. The pruned networks are illustrated
in Figures 5.13 and 5.14 for different values of ECs.
As mentioned, for the illustrated pruned networks, first the simulation of blood flow
through capillaries and fluid flow in tissue are solved based on governing equations pre-
sented in section 5.3, without the assumption of non-continuous properties of blood in
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Figure 5.12: Contour of interstitial pressure in the computational domain for both normal
and tumor tissues, assuming uniform distribution and constant values for intravascular
pressure. The maximum pressure is around 500Pa in the tumor region.
Figure 5.13: Vascular network after pruning for a network with 5 ECs in the parent vessel.
The green lines show the pruned network. The blue lines are killed segments that do not
make a loop.
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Figure 5.14: Vascular network after pruning for a network with 10 ECs in the parent vessel.
The green lines show the pruned network. The blue lines are killed segments that do not
make a loop.
capillaries and changes of capillary diameter due to metabolic and hemodynamic stimuli.
In this simulation, the capillary diameter is prescribed using a method presented by Wu
et al. [108], the hematocrit in the vessels is assumed to be constant and equal to 45% [64].
The viscosity for each segment is calculated based on Equation 5.14. The algorithm intro-
duced before is used, except that the D,H and µ are assumed to have constant values that
do not change in the iteration procedure. The 3D graph of interstitial pressure is shown
in Figures 5.15 and 5.16 for different numbers of ECs. The 2D contour is also illustrated
in Figures 5.17 and 5.18. This method results in higher pressure in the solid tumor region
for both networks.
For more-realistic simulation of the problem, the effects of non-Newtonian blood rheol-
ogy, non-uniform distribution of hematocrit in bifurcation due to non-continuous behavior
of blood and remodeling of the network due to adaptability of capillary are coupled to
the previous approach. Figures 5.19 and 5.20 show the fluid flow for a network with both
adaptable and rigid capillary. Results show uniform distribution of flow in the adaptable
capillary network. Results for intravascular pressure in the two cases are presented in Fig-
ures 5.21 and 5.22. The pressure at the right side of domain, the solid tumor region, is
higher than that of the rigid network. In fact, based on Starling law, the higher intravas-
cular pressure can increase the transvascular flow and slightly affect interstitial flow.
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Figure 5.15: 3D graph of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 5 ECs in the parent vessel
Figure 5.16: 3D graph of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 10 ECs in the parent vessel
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Figure 5.17: Contour of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 5 ECs in the parent vessel. The maximum pressure
is about 700Pa in the tumor region.
Figure 5.18: Contour of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 10 ECs in the parent vessel. The maximum pressure
is about 800Pa in the tumor region.
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Figure 5.19: Fluid flow in rigid and adaptable capillary network for network with 5 ECs
Figure 5.20: Fluid flow in rigid and adaptable capillary network for network with 10 ECs
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Figure 5.21: Intravascular pressure in the two cases simulated: rigid network and adaptable
capillary for the network with 5 ECs. The adaptable network shows higher pressure near
the solid tumor. This pressure can affect interstitial fluid flow in this region.
Figure 5.22: Intravascular pressure in the two cases simulated: rigid network and adaptable
capillary for the network with 10 ECs. The adaptable network shows higher pressure near
the solid tumor. This pressure can affect interstitial fluid flow in this region.
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Figure 5.23: 3D graph of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 5 ECs in the parent vessel
Figures 5.23 and 5.24 show the interstitial pressure in normal and tumor tissues when
the adaptation method and phase distribution in the network are considered. 2D contours
are illustrated in Figures 5.25 and 5.26. Results show higher pressure than in other cases
introduced previously in this study.
5.7 Discussion
To accurately predict chemotherapy success, researchers must be able to precisely calculate
the interstitial and intravascular pressure of tumors. In many studies, the intravascular
pressure is considered to be constant in the fluid flow modeling of tissues which is not
an accurate reflection of reality. This study simultaneously simulates the fluid flow in a
tumor-induced capillary network and the interstitial fluid flow in normal and tumor tissues.
For all simulations, a rectangular 2D domain, shown in Figure 5.7, is considered, in which
a circular tumor is located on one side and the parent vessel is located on the opposite
side.
To clarify the effect of considering a network on interstitial flow in tumor and surround-
ing tissue, for the first approach, the fluid flow in the interstitium is simulated without
considering a network. In other words, the governing equation for interstitial fluid is solved
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Figure 5.24: 3D graph of interstitial pressure in the computational domain for both normal
and tumor tissues for a network with 10 ECs in the parent vessel
Figure 5.25: 2D contour of interstitial pressure in the computational domain for both
normal and tumor tissues for a network with 5 ECs in the parent vessel. The maximum
pressure is above 1100Pa in the tumor region.
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Figure 5.26: 2D contour of interstitial pressure in the computational domain for both
normal and tumor tissues for a network with 10 ECs in the parent vessel. The maximum
pressure is above 1200Pa in the tumor region.
for the above-mentioned domain with an assumed constant value for blood pressure and
uniform distribution of the source term in the Darcy’s equation. The values calculated for
the interstitial pressure of a 0.2mm radius solid tumor located in a 2mm× 2mm domain,
shown in Figures 5.11 and 5.12, show that the maximum pressure is approximately 500Pa.
Numerical results show that the interstitial pressure value is at its maximum at the center
of the tumor and decreases towards the periphery, thus showing good agreement with re-
sults in the literature [92, 93]. As mentioned in previous studies, the governing equation
is the combination of Darcy’s law and the continuity equation that considers a uniform
source of mass flow from vessels through Starling equation [92, 93].
To investigate the effect of a capillary network on flow characteristics in normal and
tumor tissues, the tumor-induced capillary network is generated by a discrete angiogenesis
model. Two networks are produced, one with five endothelial cells and the other with ten
endothelial cells on the parent vessel.
As mentioned, two approaches, rigid and adaptable capillary networks, are studied.
The comparison of blood flow illustrated in Figures 5.19 and 5.20 for the two networks
shows that the blood flow in the capillary network for the remodeled networks has a more
logical distribution than the networks with rigid capillaries. To show these results, another
pruning method is also applied to eliminate those capillaries that have a flow rate of less
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than 1% of the network’s maximum flow rate. In the first approach, many capillaries near
the tumor are eliminated; however, in the remodeled network, these capillaries remain.
The proper distribution of blood flow in the remodeled network that causes decreased
blood-flow resistance far from the parent vessel increases the value of intravascular pressure
in the network, especially near the tumor, as shown in Figures 5.21 and 5.22. This increased
intravascular pressure causes an increase of the rate of transvascular flow based on Starling’
equation and therefore it affects the interstitial pressure.
Results of interstitial pressure distribution for both networks and two approaches are
shown in Figures 5.15, 5.16, 5.23, and 5.24. The two approaches to blood flow modeling
through capillaries considered in the fluid flow simulation for both networks show signif-
icantly different results than those for the case without a network (uniform distribution
of vessels [92, 93]). When the size of the vessels is constant, the maximum value of the
interstitial pressure is higher than 700Pa for the network with 5 ECs initially and 800Pa
for the network with 10 ECs initially. The differences between the two networks are due
to the higher density of vessels close to the tumor region. Generally, the results show an
approximately 1.5 times increase on the maximum pressure resulting from constant and
uniform distribution of intravascular pressure.
The interstitial pressure calculations based on the third approach, an adaptable capil-
lary, to blood flow simulation through capillaries, shown in Figures 5.23 and 5.24, predict
pressure values of around 1100Pa for the network with 5 ECs initially and 1200Pa for the
network with 10 ECs initially. For both networks, the results show pressure approximately
1.5 times greater than that of the rigid network and more than two times greater than
that of the constant and uniform distribution of intravascular pressure. Thus, the results
confirm the importance of considering a network generated by tumor-induced angiogenesis
in simulations of fluid flow in normal and tumor tissues.
The contour of interstitial pressure for normal and tumor tissues without a network has
regular distribution (Figure 5.12), but the evaluation of contours in Figures 5.17, 5.18, 5.25,
and 5.26 indicates that the regular distribution of pressure is changed because of irregular
source terms of mass flow to the tissue. Comparison of Figures 5.17 and 5.18 with Figures
5.25 and 5.26 shows the effect of considering remodeling of networks, especially in a network
with an initial 10 ECs. The distribution of interstitial pressure, shown in Figure 5.18, has a
tendency to the inlet of the parent vessel. Thus, the transvascular source term has greater
value in the region near the inlet of the parent vessel. This effect is observed in blood flow
distribution (Figure 5.20).
The interstitial pressure of the remodeled network, illustrated in Figure 5.26, indicates
that the distribution of pressure has a tendency to move to the center of the domain.
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Indicative of the better distribution of blood flow in the remodeled network, the pressure
distribution in Figure 5.26 shows more-uniform distribution of the source terms calculated
based on Starling’s law. This effect is not clearly observed in the network with an initial
5 ECs, due to lower density of vessels near the tumor.
5.8 Conclusion
This study provides numerical simulation of fluid flow in normal and tumor tissues in two
situations: constant and uniform distribution of intravascular pressure in the whole domain,
and distribution of intravascular pressure based on tumor-induced vascular network, using
two methods, first a rigid vascular network, and second, an adaptable vascular network.
The interstitial pressure in the case considering a tumor-induced capillary network is higher
than that shown in the modeling without a network and in previous work by our group,
in which constant and uniform distribution of intravascular pressure was assumed. The
second method of considering a capillary network shows the highest interstitial pressure
in the tumor region. The third method assumes the capillary diameter to be adaptable
(a function of hemodynamic and metabolic stimuli), and considers phase separation of red
blood cells at bifurcation points and dependency of the blood viscosity on the diameter
and hematocrit (Fahraeus Lindqvist effect). Considering the above-mentioned phenomena
such as adaptability of vessels and non-continuous behavior of blood causes a more-uniform
blood flow distribution than that for the rigid capillary network. In the latter method,
capillaries far from a parent vessel have flow, but in the former method, using a rigid
capillary network, many of these capillaries are eliminated because of their low flow rates.
In the third approach results show the highest interstitial pressure in the tumor region. The
high pressure in the tumor region and also low transvascular flow due to low intravascular
pressure in the heterogeneous capillary network near the tumor region play a significant
role in non-uniform distribution of drug in a solid tumor.
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Chapter 6
Summary and Future Work
This thesis has introduced the problem of drug delivery to solid tumors and discussed the
details of computational fluid flow in homogenized and heterogenized solid tumors. Sim-
ulation of solid tumor microvasculature has a significant role in improving chemotherapy,
in which drug particles are introduced into a patient’s body in the hope that they will
reach tumor cells. Substantial clinical, laboratory, and theoretical research has been car-
ried out to show that fundamental understanding of drug transport to tumor cells is very
important to improving chemotherapy efficiency. Simulation results are used for predicting
how therapeutic drugs are transported to tumor cells by blood flow through capillaries and
tissues.
Solid tumor modeling involves a wide range of spatial and temporal scales. This multi-
scale nature of tumor formation makes the governing equations involved in the math-
ematical modeling highly complex to solve. Multi-scale modeling involves three scales:
convection and diffusion of fluid flow in normal and tumor tissues at the largest scale,
studied in Chapters 2 and 3; blood flow distribution through a network generated by tu-
mor angiogenesis, investigated in Chapter 4, at the middle scale; and simulation of blood
flow convection in capillary vessels by considering non-continuous behavior of blood and
adaption of diameter at the smallest scale, implemented in Chapter 5.
For the purposes of discussion, in homogenized tumors (Chapters 2 and 3), vascula-
ture was first assumed to be distributed uniformly and tumor shapes were assumed to
be idealized. Then other, irregular shapes, such as prolate and oblate solid tumors, were
considered. In heterogenized tumors (Chapters 4 and 5), the capillary network model of
angiogenesis was applied to make a more-realistic model of vasculature in both tumor and
normal tissues.
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The distributions of interstitial fluid pressure and velocity have been calculated by
numerical solutions of the governing equations. Comparison of these numerical solutions
and experimental data in the literature shows that the maximum value for the interstitial
pressure occurs at the center of the tumor and decreases towards the periphery and that the
numerical values of interstitial fluid velocity and the experimental results reported in the
literature agree. Interstitial fluid pressure is not uniform, whether the tumor vasculature
is homogeneous or heterogeneous. Thus, in addition to the heterogeneous distribution of
blood supply, high interstitial pressure plays a significant role in drug distribution in a
solid tumor.
This study has introduced two new parameters, the critical tumor radius and critical
necrotic radius. Simulation results show that for tumors below the critical tumor radius, the
maximum interstitial fluid pressure is less than effective pressure; therefore, the transport
of the drug to the center of smaller tumors is much easier than transport to the center of a
tumor whose radius is greater than the critical tumor radius, as the maximum interstitial
fluid pressure is much lower than effective pressure. This study shows that there is a critical
necrotic radius, below which the interstitial fluid pressure at the center of the tumor is at
its maximum value. If the tumor radius is greater than the critical tumor radius, this
maximum pressure is equal to the effective pressure. Above this critical necrotic radius,
the interstitial fluid pressure at the center of the tumor is below effective pressure.
This thesis has also shown that, as a rule, it is not true that the leakier the vessels,
the higher the value of convective transport of drugs to solid tumors. The results do show
that only in spherical solid tumors with a radius of less than 0.25cm, or in spheroidal ones
with the same volume, can drug convection be increased by making vessels more leaky.
For spheroidal shapes, the convection of drugs inside is higher than it is in spherical ones,
and it seems that for more irregular shapes, which are generally found in the body due
to limitations imposed by neighboring tissues and organs such as the brain, this effect is
more marked. For shapes studied in this dissertation, results show that the dependency of
the maximized flux on size is much stronger than its dependency on shape. It should be
mentioned that due to very low diffusivity, the high permeability of vessels cannot support
homogeneous distribution inside tumors because this high value results in more diffusive
transport only in a narrow area around the vessels.
In real cases of solid tumors, instead of assuming uniform distribution of vessels, it is
better to use tumor-induced microvasculature. There are different models of angiogenesis.
This study presents modifications of some features of the previously presented continuous
and discrete models. These modifications are on the initial distribution of fibronectin and
TAF in the domain and also in the interpretation of the effect of MDE in the continuous and
discrete models. One of the main advantages of this work is the realistic probability dis-
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tribution in the domain. Fibronectin degradation is clearly shown to establish haptotactic
movement, and in the absence of MDE, the expected haptotactic movement decreases.
Having set the capillary network, numerical simulation of fluid flow in normal and can-
cerous tissues was finally studied under three conditions: constant and uniform distribution
of intravascular pressure in the whole domain, a rigid vascular network, and an adaptable
vascular network. The effect of tumor-induced vascular networks on fluid flow in normal
and cancerous tissues is also investigated, as are the numerical simulation for blood flow in
a microvascular network and fluid flow in the interstitium. First, fluid flow in the normal
and cancerous tissue is simulated without considering a network of vessels and uniform
distribution and constant values for blood pressure in tissues. Results of this simulation
show the distribution and values of interstitial pressure in the normal and cancerous tis-
sues. Then, two vascular networks with different numbers of initial ECs on parent vessels
are generated using a discrete angiogenesis method.
Two approaches to simulating blood flow in networks can be employed. The first
approach neglects the effect of the non-continuum and adaptability of vessels and considers
Poiseuille equation’s parameters such as the diameter of vessels and blood viscosity in the
network to be constant and ignores the phase separation of blood in vessel bifurcation.
These numerical solutions show that the interstitial pressure value is at its maximum at
the center of the tumor and decreases towards the periphery. Results show that the second,
more realistic approach has better distribution of fluid flow that the first one. This second
approach regards vessel diameter as adaptable (a function of hemodynamic and metabolic
stimuli), and considers phase separation of red blood cells at bifurcation points. The blood
viscosity depends on the diameter and hematocrit (Fahraeus Lindqvist effect). Still in the
second approach, vessels far from a parent vessel have flow, but in the first approach, many
of these vessels are eliminated because of their low flow rates. The interstitial pressure in
these two approaches is higher than that shown in the modeling without a network and
previous work by our group in which constant and uniform distribution of intravascular
pressure was assumed. In the second approach to blood flow simulation, with a more-
realistic model for blood and vessel diameter, results show the highest interstitial pressure
in the solid region, a situation that results in lower values of drug delivered to this part of
a solid tumor. This result confirms experimental data in the literature.
The problem studied in this thesis is fairly complicated even with respect to the current
knowledge about transport phenomena in biological tissues. This work is, however, still a
limited study in many respects. Some of the limitations are due to technical constraints.
First of all, the main assumption was that drug and interstitial fluid have the same velocity.
To consider a more-realistic model we should solve the concentration equation involving
advection and diffusion terms. Although not presented in the thesis, this step has been done
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for spherical and spheroidal solid tumors but not for tumors with heterogenious distribution
of microvessels. However, we leave this topic for a future study numerically quantifing this
effect in all different cases. In the angiogenesis model, a number of key assumptions
merit more discussion. Other interesting areas needing investigation are missing from the
literature, as listed below. We also leave these for future consideration.
• Study the 3D capillary network model of angiogenesis and investigate fluid flow and
solute equations in this network,
• Study the effect of the size and physical properties of solid tumors and physicochem-
ical properties of drugs,
• Improve current models to include nanoparticle drug delivery to solid tumors in
which nanoparticles have a velocity different from that of fluid, based on a continuum
approach that will result in a model as a function of time and space,
• Solve the solute and fluid equations simultaneously as a multi-scale problem in more
irregular shapes of solid tumors, which are generally found in the body due to limi-
tations imposed by neighboring tissues and structures such as the skull,
• Study the fluid and mass transport of nanoparticles and solve their governing equa-
tions in a solid tumor for which the structure is known completely from image pro-
cessing methods such as high resolution MRI or micro CT,
• Improve the model used in this thesis to include the heterogeneity and discontinuous
form of blood vessels in solid tumors, such as with a model based on the three well-
known regions of a solid tumor,
• Consider tumor growth (in a dynamic model) based on network vasculature remod-
eling to show the effect of fluid flow on angiogenesis and capillary formation,
• Investigate the effect of angiogenesis inhibition on the resulting capillary network,
• Investigate in detail the haptotactic movemnt mechanism in the discrete model of
angiogenesis,
• Use in vivo and in vitro studies to compare the effect of matrix density and angio-
genesis inhibition on the resulting capillary network,
• Study the effect of interstitial pressure in the angiogenesis process,
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• Carry out sensitivity analysis in a fluid flow model, and
• Investigate the effect of interstitial pressure in the remodeling process.
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